http://www.pharmajournalist.com/redhill-announces-u-s-co-promotion-agreement-with-napo-pharmaceuticals-for-hiv-aids-anti-diarrheal-drug-mytesi/ 2018-06-29T09:21:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/redhill-biopharma-logo.png http://www.pharmajournalist.com/purdue-pharma-announces-successful-completion-of-first-in-human-study-for-oncology-therapy-candidate-tinostamustine/ 2018-06-29T09:24:33+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Purdue-Pharma.jpg http://www.pharmajournalist.com/nucleobio-concludes-preliminary-tests-for-new-drug-to-treat-aggressive-prostate-cancer/ 2018-06-29T09:26:35+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/NucleoBio-Logo.png http://www.pharmajournalist.com/erimos-pharmaceuticals-announces-phase-i-oral-study-of-terameprocol-em-1421/ 2018-06-29T09:29:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.jpg http://www.pharmajournalist.com/isoplexis-announces-research-collaboration-with-nektar-therapeutics/ 2018-06-29T09:32:36+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/isoplexis_Logo.png http://www.pharmajournalist.com/roche-expands-access-to-the-mysugr-integrated-diabetes-management-solution-in-the-u-s-and-canada/ 2018-06-29T09:33:57+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Roche-Logo.jpeg http://www.pharmajournalist.com/wuxi-biologics-and-harbour-biomed-announce-strategic-development-and-manufacturing-partnership/ 2018-06-29T09:36:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/wuxi-biologics-logo.png http://www.pharmajournalist.com/abbvie-and-calico-announce-extension-of-groundbreaking-collaboration/ 2018-06-29T09:40:22+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/abbvie-logo.jpg http://www.pharmajournalist.com/evotec-achieves-second-milestone-in-diabetes-alliance-with-sanofi/ 2018-06-29T09:42:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/evotec.png http://www.pharmajournalist.com/shire-receives-fda-approval-for-new-plasma-manufacturing-facility-near-covington-georgia/ 2018-06-29T09:45:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/shire-pharmaceuticals.jpg http://www.pharmajournalist.com/mustang-bio-announces-opening-of-car-t-cell-therapy-manufacturing-facility-in-worcester-mass/ 2018-06-29T09:51:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/mustang-bio-logo.jpg http://www.pharmajournalist.com/sanofi-and-advent-finalize-negotiations-for-the-acquisition-of-zentiva/ 2018-06-29T09:56:32+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/lumicks-astrazeneca-and-university-of-cambridge-create-new-drug-discovery-and-biology-center/ 2018-06-29T09:58:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/starpharma-licenses-vivagel-bv-to-mundipharma-for-europe/ 2018-06-29T10:03:01+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/StarPharma-Logo.png http://www.pharmajournalist.com/xeljanz-tofacitinib-citrate-receives-marketing-authorisation-in-the-european-union-for-active-psoriatic-arthritis/ 2018-06-29T10:05:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/pivotal-and-apro-partner-to-develop-3-investigator-sponsored-trials-in-genitourinary-tumors/ 2018-07-06T07:13:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Pivotal-Logo.png http://www.pharmajournalist.com/juniper-pharma-signs-definitive-agreement-to-be-acquired-by-catalent-for-11-50-per-share-in-cash/ 2018-07-06T07:16:01+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/juniper_pharma_logo.png http://www.pharmajournalist.com/sorrento-acquires-the-sofusa-lymphatic-delivery-platform-for-immune-oncology-i-o-antibody-therapeutics/ 2018-07-06T07:18:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/sorrento-therapeutics.jpg http://www.pharmajournalist.com/sanofi-to-further-accelerate-its-scientific-presence-with-the-opening-of-a-global-rd-operations-hub-in-chengdu-china/ 2018-07-06T07:20:12+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/new-triple-therapy-could-boost-treatment-and-prevent-relapse-of-advanced-breast-cancer/ 2018-07-06T07:24:07+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Micrograph-of-breast-cancer-cells.jpg https://www.pharmajournalist.com/wp-content/uploads/2018/07/Micrograph-of-breast-cancer-cells.jpg http://www.pharmajournalist.com/fda-approves-aristada-initio-for-the-initiation-of-aristada-for-schizophrenia/ 2018-07-06T07:27:35+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/Alkermes-logo.jpg http://www.pharmajournalist.com/evotec-confirm-closing-of-transaction-with-sanofi-to-accelerate-infectious-disease-rd/ 2018-07-06T07:30:27+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/european-chmp-adopts-positive-opinion-for-yescarta-axicabtagene-ciloleucel/ 2018-07-06T07:32:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/broad-and-bayer-expand-partnership-launching-new-research-effort-to-develop-therapies-for-heart-failure/ 2018-07-06T07:34:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/bayer.jpg http://www.pharmajournalist.com/akebia-therapeutics-to-merge-with-keryx-biopharmaceuticals/ 2018-07-06T07:37:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/akebia-pharma-logo.png http://www.pharmajournalist.com/eisai-and-biogen-announce-positive-topline-results-of-the-final-analysis-for-ban2401-at-18-months/ 2018-07-06T07:40:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Biogen-logo.jpg http://www.pharmajournalist.com/theratechnologies-submits-novel-single-vial-formulation-of-egrifta-tesamorelin-for-injection-for-fda-approval/ 2018-07-06T07:43:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/drug.jpg http://www.pharmajournalist.com/forendo-pharma-initiates-phase-i-study-for-potential-new-targeted-treatment-for-endometriosis/ 2018-07-06T07:45:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical.jpg http://www.pharmajournalist.com/fda-approves-xeomin-incobotulinumtoxina-for-adult-patients-with-sialorrhea/ 2018-07-06T07:47:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/menarini-and-orion-sign-regional-partnerships-in-asia-pacific/ 2018-07-06T07:52:05+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Menarini-Asia-Pacific-Logo.jpg http://www.pharmajournalist.com/ucb-announces-approval-of-neupro-in-china-to-treat-parkinsons-disease/ 2018-07-06T07:56:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/ucb-pharma.jpg http://www.pharmajournalist.com/adamis-pharma-announces-distribution-and-commercialization-agreement-for-symjepi/ 2018-07-06T08:02:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/drug-discovery.jpg http://www.pharmajournalist.com/owc-pharmaceutical-research-corp-completes-first-part-of-cannabis-based-ointment-safety-study/ 2018-07-06T08:06:24+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/OWC-Pharma-Logo.jpg http://www.pharmajournalist.com/almac-discovery-appoints-dr-xavier-jacq-as-vice-president-biology/ 2018-07-06T08:10:36+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Dr.-Xavier-Jacq.png https://www.pharmajournalist.com/wp-content/uploads/2018/07/Dr.-Xavier-Jacq.png http://www.pharmajournalist.com/jazz-pharma-enters-into-agreement-with-tersera-therapeutics-llc-for-prialt/ 2018-07-06T08:12:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/jazz-pharmaceuticals.jpg http://www.pharmajournalist.com/recipharm-launches-standalone-serialisation-service/ 2018-07-06T08:14:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/recipharm.jpg http://www.pharmajournalist.com/agilent-technologies-to-expand-biopharma-consumables-portfolio-with-acquisition-of-prozyme/ 2018-07-06T08:16:49+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/agilent-logo.png http://www.pharmajournalist.com/abcam-merck-collaboration-produces-new-pd-l1-antibody-for-immuno-oncology-research/ 2018-07-06T08:32:46+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Abcam-Logo.jpg http://www.pharmajournalist.com/acceleron-appoints-robert-k-zeldin-m-d-chief-medical-officer/ 2018-07-06T08:37:52+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Robert-K.-Zeldin.jpg https://pharmajournalist.com/wp-content/uploads/2018/07/Robert-K.-Zeldin.jpg http://www.pharmajournalist.com/trigr-therapeutics-and-abl-bio-announce-global-oncology-collaboration-on-pipeline-of-next-generation-therapeutic-antibodies/ 2018-07-06T08:42:20+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/TRIGR-Therapeutics-Logo.jpg http://www.pharmajournalist.com/lynparza-approved-in-japan-for-brca-mutated-metastatic-breast-cancer/ 2018-07-06T08:44:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/patient-organisations-role-in-orphan-drugs-clinical-development/ 2018-07-09T08:23:09+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/ODRD_AKUNPUK_Interview.jpg https://www.pharmajournalist.com/wp-content/uploads/2018/07/ODRD_AKUNPUK_Interview.jpg http://www.pharmajournalist.com/cure-pharmaceutical-plans-to-acquire-cannabinoid-based-drug-pipeline-from-therapix-biosciences/ 2018-07-12T14:50:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/drug-discovery.jpg http://www.pharmajournalist.com/biontech-and-genevant-sciences-sign-strategic-mrna-focused-partnership-in-rare-diseases/ 2018-07-12T14:53:02+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/BioNTech.jpg https://www.pharmajournalist.com/wp-content/uploads/2018/07/BioNTech.jpg http://www.pharmajournalist.com/boehringer-ingelheim-acquires-mabvaxs-programme-for-solid-tumours/ 2018-07-12T14:55:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/biocryst-pharmaceuticals-announces-termination-of-merger-agreement-with-idera-pharmaceuticals/ 2018-07-12T14:57:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/biocryst-pharma-logo.jpg http://www.pharmajournalist.com/mylan-adds-to-central-nervous-system-portfolio-with-launch-of-generic-exelon-patch/ 2018-07-12T14:58:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/mylan-1.jpg http://www.pharmajournalist.com/axovant-and-benitec-estbalish-gene-therapy-partnership/ 2018-07-12T15:02:52+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/AXOVANT_Logo.jpg http://www.pharmajournalist.com/herantis-pharma-to-develop-non-invasive-cdnf-for-parkinsons/ 2018-07-12T15:06:41+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/HERANTIS_logo.png http://www.pharmajournalist.com/otsuka-pharmaceutical-to-acquire-visterra/ 2018-07-12T15:08:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/otsuka-europe.jpg http://www.pharmajournalist.com/sri-international-announces-drug-research-collaboration-with-ionis-pharmaceuticals/ 2018-07-12T15:09:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/ionis-pharma1.jpg http://www.pharmajournalist.com/teva-announces-launch-of-a-generic-version-of-uceris-in-the-united-states/ 2018-07-12T15:13:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/TEVA-Pharma.jpg http://www.pharmajournalist.com/ul-and-applied-dna-announce-strategic-partnership/ 2018-07-12T15:19:08+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Partnership.jpg http://www.pharmajournalist.com/pfenex-receives-merck-milestone-payment/ 2018-07-12T15:22:11+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/pfenex.png http://www.pharmajournalist.com/genmab-enters-strategic-partnership-with-immatics-to-discover-and-develop-next-generation-bispecific-cancer-immunotherapies/ 2018-07-12T15:25:06+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Genmab-Logo.jpg http://www.pharmajournalist.com/symphogen-a-s-and-selexis-expand-relationship-as-symphogen-advances-its-monoclonal-antibody-mab-mixture-pipeline/ 2018-07-12T15:28:18+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Selexis-Cell-Line-Development.jpg https://pharmajournalist.com/wp-content/uploads/2018/07/Selexis-Cell-Line-Development.jpg http://www.pharmajournalist.com/bioivt-acquires-optivia-biotechnology/ 2018-07-12T15:30:38+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Partnership.jpg http://www.pharmajournalist.com/international-stem-cell-corporation-expands-manufacturing-capabilities-for-biomedical-products/ 2018-07-12T15:33:15+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/isco-logo.jpg http://www.pharmajournalist.com/catalent-biologics-adopts-berkeley-lights-beacon-optofluidic-platform-to-accelerate-cell-line-development/ 2018-07-12T15:34:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Catelent-Office.png http://www.pharmajournalist.com/filament-biosolutions-announces-collaboration-with-ajinomoto/ 2018-07-12T15:37:12+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Filament-Biosolutions-Logo.png http://www.pharmajournalist.com/amphastar-announces-expansion-of-amphastar-nanjing-pharmaceuticals/ 2018-07-12T15:39:31+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Amphastar.jpg http://www.pharmajournalist.com/immatics-enters-into-a-strategic-partnership-with-genmab-to-develop-next-generation-bispecific-cancer-immunotherapies/ 2018-07-13T08:28:56+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/immatics-logo.jpg http://www.pharmajournalist.com/antabio-completes-e-12-5m-series-a/ 2018-07-13T08:31:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Antabio-Logo.png http://www.pharmajournalist.com/probiogen-and-pionyr-immunotherapeutics-initiate-a-second-immuno-oncology-contract-development-and-manufacturing-project/ 2018-07-13T08:33:27+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/ProBioGen-Logo.png http://www.pharmajournalist.com/sirona-biochem-announces-cfda-approval-of-sglt2-inhibitor-for-phase-i-clinical-trial/ 2018-07-13T08:35:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/fda-grants-priority-review-to-mercks-sbla-for-keytruda-to-treat-advanced-hepatocellular-carcinoma/ 2018-07-13T08:39:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/abbvies-blood-cancer-drug-ibrutinib-fails-in-phase-3-dlbcl-trial/ 2018-07-13T08:42:25+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/smis-biosimilars-biobetters-exclusive-interview-with-expert-speaker-dr-michel-mikhail-released/ 2018-07-16T08:49:06+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/Biosimilars-Biobetters_Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/optimization-of-lyophilization-and-alternatives-to-conventional-freeze-drying-methods/ 2018-07-16T08:51:00+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Lyophilization-USA_SMi_Pharma-Journalist.jpg https://www.pharmajournalist.com/wp-content/uploads/2018/07/a.jpg http://www.pharmajournalist.com/medimmune-expert-speaker-interview-released-in-run-up-to-immuno-oncology-conference/ 2018-07-16T08:51:36+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Immuno-Oncology-Banner-SMi-Pharma-Journalist.jpg https://www.pharmajournalist.com/wp-content/uploads/2018/07/c.jpg http://www.pharmajournalist.com/w-j-wiess-and-a-s-lynch-invitation-to-smis-superbugs-superdrugs-usa-conference/ 2018-07-16T08:51:51+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Superbugs-Superdrugs-USA_SMi_Pharma-Journalist.jpg https://www.pharmajournalist.com/wp-content/uploads/2018/07/b.jpg http://www.pharmajournalist.com/exclusive-interview-with-dr-dennis-jenke-on-chinese-regulations-challenges-faced-and-more/ 2018-07-17T15:24:59+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/EL-China_Pharma-Journalist.png http://www.pharmajournalist.com/fda-grants-breakthrough-therapy-designation-for-roches-tecentriq/ 2018-07-19T13:44:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/sanofi-and-revolution-medicines-partner-to-develop-cancer-treatments/ 2018-07-19T13:45:48+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/fda-grants-orphan-drug-designation-to-asceneurons-tau-modifier-asn120290/ 2018-07-19T13:47:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/janssen-announces-fda-approval-of-symtuza-str-for-hiv-1/ 2018-07-19T13:55:38+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Symtuza-Janssen.jpg https://www.pharmajournalist.com/wp-content/uploads/2018/07/Symtuza-Janssen.jpg http://www.pharmajournalist.com/abbvie-announces-humira-adalimumab-patent-license-with-mylan/ 2018-07-19T13:57:49+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/abbvie-logo.jpg http://www.pharmajournalist.com/new-als-therapy-in-clinical-trials/ 2018-07-19T14:02:37+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Bucelli_ALSpatient.jpg https://www.pharmajournalist.com/wp-content/uploads/2018/07/Bucelli_ALSpatient.jpg http://www.pharmajournalist.com/fda-approves-the-first-drug-with-an-indication-for-treatment-of-smallpox/ 2018-07-19T14:04:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/roivant-subsidiary-dermavant-sciences-signs-agreement-with-gsk-to-purchase-rights-to-tapinarof/ 2018-07-19T14:07:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/polyu-axis-therapeutics-joint-center-for-immunotherapy-launched-to-develop-innovative-cancer-treatments/ 2018-07-19T14:11:01+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/PolyU-Axis-Therapeutics.jpg https://www.pharmajournalist.com/wp-content/uploads/2018/07/PolyU-Axis-Therapeutics.jpg http://www.pharmajournalist.com/advanced-proteome-therapeutics-announces-collaboration-with-noria-pharmaceuticals/ 2018-07-19T14:13:08+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Partnership.jpg http://www.pharmajournalist.com/nohla-therapeutics-receives-fda-orphan-drug-designation-for-dilanubicel-for-hematopoietic-stem-cell-transplant-patients/ 2018-07-19T14:25:28+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Nohla-Therapeutics-Logo.jpg http://www.pharmajournalist.com/edge-pharmacy-services-bringing-new-unit-dose-pharmaceutical-products-to-canada-through-acquisition-of-apolab/ 2018-07-19T14:28:16+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Edge-Pharmacy-Services.png http://www.pharmajournalist.com/morphosys-and-galapagos-sign-global-license-agreement-for-mor106-with-pharma-partner/ 2018-07-19T22:47:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/kite-and-gadeta-announce-strategic-collaboration-to-advance-gamma-delta-t-cell-receptor-technology-for-solid-tumors/ 2018-07-19T22:50:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/sterigenics-expands-european-capacity-with-new-state-of-the-art-gamma-sterilization-facility-in-the-uk/ 2018-07-19T22:57:35+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Sotera-Health-Logo.jpg http://www.pharmajournalist.com/takeda-and-ovid-therapeutics-expand-clinical-program/ 2018-07-19T23:00:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/taconic-biosciences-and-cyagen-biosciences-announce-strategic-partnership/ 2018-07-19T23:02:33+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Partnership.jpg http://www.pharmajournalist.com/innovest-global-acquires-stake-in-stemvax-therapeutics/ 2018-07-19T23:05:50+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Partnership.jpg http://www.pharmajournalist.com/leon-nanodrugs-supports-takeda-in-a-feasibility-assessment-of-leons-proprietary-microjet-reactor-mjr-nano-technology/ 2018-07-19T23:11:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/cryoport-partners-with-world-courier-to-provide-logistics-platform-for-global-cell-and-gene-therapy-market/ 2018-07-19T23:24:23+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Cryoport-Logo.jpg http://www.pharmajournalist.com/sinovant-sciences-and-renexxion-form-partnership-to-develop-naronapride-in-china/ 2018-07-19T23:26:15+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Partnership.jpg http://www.pharmajournalist.com/medical-fair-china-2018-visitor-pre-registration-now-open-register-now-to-enjoy-multiple-benefits/ 2018-07-23T05:54:07+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Medical-Fair-China_Banner_Pharma-Journalist.gif https://pharmajournalist.com/wp-content/uploads/2018/07/img-1.jpg https://pharmajournalist.com/wp-content/uploads/2018/07/img-2.jpg http://www.pharmajournalist.com/smis-exclusive-interview-with-medimmune-principal-scientist-just-released/ 2018-07-25T12:33:46+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Superbugs-Superdrugs-USA_SMi_Pharma-Journalist.jpg http://www.pharmajournalist.com/logipharma-an-annual-gathering-of-supply-chain-leaders/ 2018-07-26T16:12:54+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Logipharma-USA.jpg http://www.pharmajournalist.com/bristol-myers-squibb-sandoz-amerisourcebergen-genetech-and-more-joining-the-logipharma-2018-conference/ 2018-07-26T16:14:51+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Logipharma-USA.jpg http://www.pharmajournalist.com/bms-and-tsinghua-university-enter-clinical-research-collaboration/ 2018-07-27T07:34:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/gsk-and-23andme-sign-agreement-to-leverage-genetic-insights-for-the-development-of-novel-medicines/ 2018-07-27T07:36:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/abbvie-receives-fda-approval-of-orilissa-for-endometriosis-pain/ 2018-07-27T07:39:34+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/puretech-health-announces-collaboration-with-roche-to-advance-technology-for-oral-administration-of-antisense-oligonucleotides/ 2018-07-27T07:42:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/keytruda-pembrolizumab-is-the-first-anti-pd-1-therapy-approved-in-china-for-advanced-melanoma/ 2018-07-27T07:45:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/genprex-enters-agreement-with-the-university-of-texas-md-anderson-cancer-center-to-study-oncoprex-in-combination-with-immunotherapies/ 2018-07-27T07:48:15+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Partnership.jpg http://www.pharmajournalist.com/innovent-receives-ind-approval-to-initiate-clinical-trials-in-china-with-its-anti-ox40-agonistic-antibody-ibi101-and-its-anti-rankl-antibody-ibi307/ 2018-07-27T07:51:15+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/innovent-biologics-logo.png http://www.pharmajournalist.com/medisca-announces-exclusive-partnership-with-german-manufacturer-samix/ 2018-07-27T07:55:27+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/MEDISCA-Logo.png http://www.pharmajournalist.com/cambrex-to-acquire-halo-pharma-adding-drug-development-and-finished-dosage-capabilities-to-global-api-manufacturing-network/ 2018-07-27T07:58:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/cambrex-logo.png http://www.pharmajournalist.com/adamis-pharmaceuticals-adds-sublingual-erectile-dysfunction-product-candidate-to-its-pipeline/ 2018-07-27T08:04:02+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Adamis-Logo.jpg http://www.pharmajournalist.com/wuxi-stas-jinshan-site-passes-fourth-u-s-fda-inspection/ 2018-07-27T08:08:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/wuxi-apptec-logo.png http://www.pharmajournalist.com/athenex-announces-that-two-phase-3-pivotal-efficacy-studies-of-kx2-391-in-actinic-keratosis-achieved-their-primary-endpoints/ 2018-07-27T08:12:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/q-biomed-extends-its-exclusive-option-agreement-with-washington-university/ 2018-07-27T08:15:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical.jpg http://www.pharmajournalist.com/wuxi-biologics-announced-successful-completion-of-the-first-cgmp-run-in-mfg3/ 2018-07-27T08:17:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/wuxi-biologics-logo.png http://www.pharmajournalist.com/ppd-expands-central-labs-preclarus-technology/ 2018-07-27T08:19:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/PPD-office_wikipedia.jpg http://www.pharmajournalist.com/ppd-names-ron-garrow-as-chief-human-resource-officer/ 2018-07-27T08:21:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/PPD-office_wikipedia.jpg http://www.pharmajournalist.com/convelo-therapeutics-to-develop-new-regenerative-medicines-for-neurological-disease-characterized-by-loss-of-myelin/ 2018-07-27T08:30:55+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Convelo-Logo.png http://www.pharmajournalist.com/pfizer-to-build-cutting-edge-sterile-injectable-facility-in-michigan/ 2018-07-27T08:33:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/immunomedics-announces-clinical-collaboration-with-astrazeneca-in-first-line-triple-negative-breast-and-urothelial-cancers/ 2018-07-27T08:35:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/allergan-receives-fda-fast-track-designation-for-agn-241751-for-the-treatment-of-major-depressive-disorder-mdd/ 2018-07-27T08:38:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/allergan.jpg http://www.pharmajournalist.com/koutif-therapeutics-confirms-clinical-candidate-drug/ 2018-07-27T08:42:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.png http://www.pharmajournalist.com/talks-from-the-mhra-innovate-uk-plasticell-and-more-at-smis-cell-gene-therapy-conference/ 2018-08-01T15:35:39+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Cell-Gene-Therapy-2018-Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/industry-news-with-an-exclusive-interview-from-aerie-pharmaceuticals-for-ophthalmic-drugs-2018/ 2018-08-01T15:41:34+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Ophthalmic-Drugs_SMi_Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/iatas-ceiv-pharma-certification-or-hsas-gdp-certification/ 2018-08-02T08:13:09+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Cold-Chain-Distribution-SMi-Banner-Pharma-Journalist.jpg http://www.pharmajournalist.com/shionogi-announces-fda-approval-of-mulpleta-lusutrombopag/ 2018-08-03T07:42:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/shionogi-logo.jpg http://www.pharmajournalist.com/pfizer-receives-european-approval-for-oncology-biosimilar-trazimera-trastuzumab/ 2018-08-03T07:43:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/takeda-to-produce-innovative-drug-for-multiple-myeloma-patients-in-yaroslavl-russia/ 2018-08-03T07:46:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/takeda-completes-its-acquisition-of-tigenix-following-expiration-of-the-squeeze-out-period/ 2018-08-03T07:47:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/leo-pharma-to-expand-its-lead-in-medical-dermatology-with-acquisition-of-bayers-prescription-dermatology-unit/ 2018-08-03T07:50:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/leo-pharma.jpg http://www.pharmajournalist.com/selumetinib-granted-orphan-designation-in-europe-for-neurofibromatosis-type-1/ 2018-08-03T07:52:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/imfinzi-receives-positive-eu-chmp-opinion-for-locally-advanced-unresectable-non-small-cell-lung-cancer/ 2018-08-03T07:53:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/novartis-marks-a-new-era-for-migraine-patients-with-the-eu-approval-of-aimovig/ 2018-08-03T07:56:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/prime-designation-granted-by-ema-for-rg6042-for-treatment-of-huntingtons-disease/ 2018-08-03T07:59:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/mannkind-and-tanner-pharma-group-enter-into-an-ex-u-s-distribution-agreement-for-afrezza/ 2018-08-03T08:03:03+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/MannKind-Logo.png http://www.pharmajournalist.com/fda-approves-perseris-risperidone-for-extended-release-injectable-suspension-for-the-treatment-of-schizophrenia-in-adults/ 2018-08-03T08:08:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/lilly-announces-extension-of-cancer-research-collaboration-with-dana-farber-cancer-institute/ 2018-08-03T08:11:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/cstones-mek-inhibitor-cs3006-receives-ind-approval-in-china/ 2018-08-03T08:13:45+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/CSStonePharma-Logo.jpg http://www.pharmajournalist.com/akcea-and-ptc-collaborate-to-commercialize-two-rare-disease-drugs-in-latin-america/ 2018-08-03T08:18:38+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Akcea-Logo.jpg http://www.pharmajournalist.com/nutriband-inc-completes-acquisition-of-4p-therapeutics-inc/ 2018-08-03T08:36:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/puma-biotechnology-files-new-drug-submission-for-nerlynx-in-canada/ 2018-08-03T08:39:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/puma-biotechnology.jpg http://www.pharmajournalist.com/nektar-therapeutics-announces-new-drug-application-for-nktr-181-accepted-for-review-by-fda/ 2018-08-03T08:41:43+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Nektar-Therapeutics-Logo.jpg http://www.pharmajournalist.com/hifibio-therapeutics-signs-multi-target-antibody-discovery-agreement-with-takeda/ 2018-08-03T08:44:52+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/HiFiBiO-Logo.png http://www.pharmajournalist.com/abdi-ibrahim-selects-rfxcel-for-fmd-compliance/ 2018-08-03T08:49:59+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/rfxcel-logo.png http://www.pharmajournalist.com/milliporesigma-and-innocore-pharmaceuticals-to-improve-patient-compliance-with-new-drug-delivery-technology/ 2018-08-03T08:51:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/MilliporeSigma.jpg http://www.pharmajournalist.com/forge-therapeutics-achieves-carb-x-milestone/ 2018-08-03T08:54:52+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Forge-Therapeutics-Logo.jpg http://www.pharmajournalist.com/torque-introduces-high-efficiency-t-cell-manufacturing-process/ 2018-08-03T09:00:06+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Torque-Logo.png http://www.pharmajournalist.com/amgen-breaks-ground-on-next-generation-biomanufacturing-plant-in-rhode-island/ 2018-08-03T09:02:52+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Rendering-of-new-next-generation-biomanufacturing-plant.jpg https://www.pharmajournalist.com/wp-content/uploads/2018/08/Rendering-of-new-next-generation-biomanufacturing-plant.jpg http://www.pharmajournalist.com/ibsa-group-establishes-commercial-operations-in-the-u-s/ 2018-08-03T09:07:28+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/IBSA-Logo.png http://www.pharmajournalist.com/pharma-packaging-labelling-serialization-track-and-trace-2018/ 2018-08-08T08:32:37+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Pharma-Packaging-2018-300x250px-size-banner.jpg https://www.pharmajournalist.com/wp-content/uploads/2018/08/Pharma-Packaging-2018-1584x396px-size-banner.jpg http://www.pharmajournalist.com/cnppa-to-join-panel-discussion-get-all-you-need-to-know-about-the-regulatory-landscape-at-el-china-2018/ 2018-08-08T11:13:21+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/EL-China_Pharma-Journalist.png http://www.pharmajournalist.com/how-challenges-including-brexit-inadequate-funding-insufficient-patient-sample-sizes-hinder-orphan-drugs-and-rare-diseases-research/ 2018-08-08T16:18:47+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Orphan.jpg http://www.pharmajournalist.com/array-biopharma-receives-fda-breakthrough-therapy-designation-for-braftovi/ 2018-08-10T07:51:23+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Array-Biopharma-Logo.jpg http://www.pharmajournalist.com/solid-tumors-targeted-in-new-car-t-cell-immunotherapy-trial/ 2018-08-10T07:54:25+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Seattle-Childrens.jpg https://www.pharmajournalist.com/wp-content/uploads/2018/08/Seattle-Childrens.jpg http://www.pharmajournalist.com/regeneron-and-bluebird-bio-announce-collaboration-to-discover-develop-and-commercialize-new-cell-therapies-for-cancer/ 2018-08-10T07:57:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/regeneron.jpg http://www.pharmajournalist.com/fda-takes-new-steps-to-encourage-the-development-of-novel-medicines-for-the-treatment-of-opioid-use-disorder/ 2018-08-10T08:00:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/glenmark-pharmaceuticals-and-harbour-biomed-sign-agreement-for-greater-china-to-develop-gbr-1302/ 2018-08-10T08:05:46+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Glenmark-Pharma-Image.jpg http://www.pharmajournalist.com/ovascience-and-millendo-therapeutics-announce-merger-to-create-leading-rare-endocrine-disease-company/ 2018-08-10T08:11:19+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/OvaScience-Logo.jpg http://www.pharmajournalist.com/carolina-biooncology-enters-into-an-agreement-with-xcellbio-for-advanced-immunotherapeutic-development/ 2018-08-10T08:14:03+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Xcell-Bioscience-Logo.jpg http://www.pharmajournalist.com/ambys-medicines-and-takeda-announce-partnership-to-pioneer-first-in-class-therapies-for-the-treatment-of-serious-liver-diseases/ 2018-08-10T08:15:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/synergy-pharmaceuticals-announces-license-agreement-with-luoxin-pharmaceutical-group-for-trulance-plecanatide-in-china/ 2018-08-10T08:18:32+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Synergy-Pharma-Logo.jpg http://www.pharmajournalist.com/tanner-pharma-group-signs-distribution-agreement-with-nephcentric-llc/ 2018-08-10T08:20:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/alteogen-gets-fda-approval-for-orphan-drug-designation-with-an-antibody-drug-conjugate-for-gastric-cancer/ 2018-08-10T08:22:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/selumetinib-granted-orphan-designation-in-europe-for-neurofibromatosis-type-1-2/ 2018-08-10T08:25:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/perrigo-announces-plan-to-separate-prescription-pharmaceuticals-business/ 2018-08-10T08:36:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/perrigo-company-logo.png http://www.pharmajournalist.com/emergent-biosolutions-to-acquire-paxvax-from-cerberus-capital-management/ 2018-08-10T08:39:16+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/emergent-biosolutions_logo.jpg http://www.pharmajournalist.com/sotera-healths-nelson-labs-announces-acquisition-of-new-jersey-based-gibraltar-laboratories/ 2018-08-10T08:43:32+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Sotera-health-Logo.png http://www.pharmajournalist.com/tracelink-joins-imvo-serialization-pilot-for-pharmacies-and-clinics/ 2018-08-10T08:45:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/tracelink-logo.png http://www.pharmajournalist.com/allergan-and-editas-medicine-announce-exercise-of-options-to-jointly-develop-crispr-genome-editing-experimental-medicine-edit-101/ 2018-08-10T08:49:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/allergan.jpg http://www.pharmajournalist.com/antares-pharma-enters-into-development-agreement-with-pfizer/ 2018-08-10T08:52:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/abzena-signs-protein-engineering-agreement-with-nyu-langone-health/ 2018-08-10T08:54:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical.jpg http://www.pharmajournalist.com/almac-discovery-elasmogen-and-innovate-uk-collaborate-to-develop-vnar-based-oncology-platform/ 2018-08-10T08:57:42+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/almac-group.png https://www.pharmajournalist.com/wp-content/uploads/2018/08/almac-group.png http://www.pharmajournalist.com/apexigen-raises-73-million-in-series-b-and-series-c-financings/ 2018-08-10T09:06:12+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Apexigen-Logo.png http://www.pharmajournalist.com/teneobio-and-poseida-expand-their-partnership-to-develop-unidabs-for-advanced-car-t-therapies/ 2018-08-10T09:08:50+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/TenoBio.jpg https://pharmajournalist.com/wp-content/uploads/2018/08/TenoBio.jpg http://www.pharmajournalist.com/scancell-extends-moditope-collaboration-with-karolinska-institute/ 2018-08-10T11:55:46+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/scancell-logo.jpg http://www.pharmajournalist.com/cambodia-phar-med-expo-2018/ 2018-08-17T08:36:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/Cambodia-Phar-Med-2018.png http://www.pharmajournalist.com/myanmar-phar-med-expo-2018/ 2018-08-17T08:47:30+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/509055924492-e1534496009674.png http://www.pharmajournalist.com/janssen-reports-positive-topline-results-for-atlas-phase-iii-study-of-a-novel-long-acting-injectable-two-drug-regimen-for-the-treatment-of-hiv-1/ 2018-08-17T08:59:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/Janssen.jpg http://www.pharmajournalist.com/nih-funded-researchers-reverse-congenital-blindness-in-mice/ 2018-08-17T09:04:16+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/photoreceptor_NIH.jpg https://pharmajournalist.com/wp-content/uploads/2018/08/photoreceptor_NIH.jpg http://www.pharmajournalist.com/biontech-signs-collaboration-agreement-with-pfizer-to-develop-mrna-based-vaccines-for-prevention-of-influenza/ 2018-08-17T09:47:20+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/BioNTech-AG.jpg https://www.pharmajournalist.com/wp-content/uploads/2018/08/BioNTech-AG.jpg http://www.pharmajournalist.com/agex-therapeutics-acquires-technology-to-regulate-immune-tolerance/ 2018-08-17T09:52:02+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/AgeX-Therapeutics-Logo.jpg http://www.pharmajournalist.com/emalex-acquires-psyadon-to-develop-novel-treatment-for-pediatric-tourette-syndrome/ 2018-08-17T09:54:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/stealth-biotherapeutics-expands-pipeline-advances-new-compound/ 2018-08-17T09:58:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/stealth-biotherapeutics-logo.png http://www.pharmajournalist.com/medicure-announces-fda-approval-of-acute-care-cardiovascular-drug-sodium-nitroprusside-injection/ 2018-08-17T10:02:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/Medicure-Inc-Logo.gif http://www.pharmajournalist.com/cancer-prevention-pharmaceuticals-completes-north-american-licensing-deal-with-mallinckrodt/ 2018-08-17T10:08:37+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Cancer-Prevention-Pharma-Logo.jpg http://www.pharmajournalist.com/astellas-announces-acquisition-of-quethera/ 2018-08-17T10:10:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astellas.jpg http://www.pharmajournalist.com/lakepharma-expands-antibody-center-into-new-40000-sq-ft-san-carlos-building/ 2018-08-17T10:15:20+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/LakePharma.jpg http://www.pharmajournalist.com/agenus-receives-second-milestone-payment-from-merck/ 2018-08-17T10:16:58+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/agenus-logo.jpg http://www.pharmajournalist.com/crownbio-expands-genetically-engineered-model-selection-via-strategic-alliance-with-smoc/ 2018-08-17T10:18:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/crownbio-logo.jpg http://www.pharmajournalist.com/altasciences-to-acquire-preclinical-safety-testing-services/ 2018-08-17T10:22:09+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Altasciences-Logo.png http://www.pharmajournalist.com/tracelink-announces-russia-compliance-solution/ 2018-08-17T10:24:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/tracelink-logo.png http://www.pharmajournalist.com/evotec-partner-haplogen-enters-into-collaboration-with-bayer/ 2018-08-17T10:28:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/evotec.png http://www.pharmajournalist.com/tjoapack-launches-postponement-packaging-service/ 2018-08-17T10:30:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/drug-discovery.jpg http://www.pharmajournalist.com/eisai-and-merck-announce-fda-approval-of-lenvima-capsules-for-treatment-of-unresectable-hcc/ 2018-08-17T10:35:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/wuxi-apptec-and-cyclica-collaborate-to-drive-polypharmacology-in-drug-discovery-through-ai-augmented-technologies/ 2018-08-17T10:37:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/wuxi-apptec-logo.png http://www.pharmajournalist.com/novocure-and-us-oncology-research-announce-collaboration-on-panova-3-trial-for-patients-with-advanced-pancreatic-cancer/ 2018-08-17T10:42:47+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Novocure-Logo.jpg http://www.pharmajournalist.com/sun-pharma-announces-fda-approval-of-cequa-to-treat-dry-eye-disease/ 2018-08-17T10:44:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/SunPharma.jpg http://www.pharmajournalist.com/inovio-announces-first-patient-dosed-in-trial-to-determine-pennvax-gps-ability-to-induce-remission-of-hiv-infection/ 2018-08-17T10:47:57+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Inovio-Pharmaceuticals-Logo.jpg http://www.pharmajournalist.com/fda-grants-orphan-drug-designation-to-onspira-therapeutics-investigational-interleukin-1-receptor-antagonist-for-the-treatment-of-bronchiolitis-obliterans/ 2018-08-17T10:51:06+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Onspira-Therapeutics-Logo.png http://www.pharmajournalist.com/fda-grants-breakthrough-therapy-designation-for-xolair-omalizumab-for-food-allergies/ 2018-08-17T10:54:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/izana-bioscience-initiates-namilumab-phase-ii-proof-of-concept-clinical-study-in-ankylosing-spondylitis/ 2018-08-17T10:57:23+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Izana-Bioscience-Logo.png http://www.pharmajournalist.com/regeneron-and-teva-announce-positive-topline-phase-3-fasinumab-results-in-patients-with-chronic-pain-from-osteoarthritis-of-the-knee-or-hip/ 2018-08-17T11:01:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/regeneron.jpg http://www.pharmajournalist.com/smis-exclusive-speaker-interview-with-abon-pharmaceuticals-director-just-released/ 2018-08-20T07:42:24+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/400x300_Lyo.jpg https://pharmajournalist.com/wp-content/uploads/2018/08/400x300_Lyo.jpg http://www.pharmajournalist.com/supply-chain-management-for-hospitals-and-healthcare/ 2018-08-20T08:09:12+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Healthcare-Supply-Chain-Management-Summit-2018-Banner-Pharma-Journalist.jpg http://www.pharmajournalist.com/invitation-from-dr-james-legg-vice-president-rd-at-crescendo-biologics-chair-of-this-years-immuno-oncology-conference-in-london/ 2018-08-20T14:36:53+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Immuno-Oncology-Banner-SMi-Pharma-Journalist.jpg http://www.pharmajournalist.com/tagrisso-approved-in-japan-for-1st-line-treatment-of-egfr-mutated-non-small-cell-lung-cancer/ 2018-08-24T09:11:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/cnda-grants-rapid-approval-of-roches-alecensa-alectinib-as-a-treatment-for-alk-positive-lung-cancer/ 2018-08-24T09:14:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/tolero-announces-clinical-research-collaboration-with-abbvie-for-acute-myeloid-leukemia-trial/ 2018-08-24T09:17:19+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/novartis-receives-ec-approval-of-its-car-t-cell-therapy-kymriah-tisagenlecleucel/ 2018-08-28T07:37:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/bluebird-bio-and-gritstone-oncology-announce-strategic-collaboration-to-develop-novel-cancer-cell-therapies/ 2018-08-28T07:39:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/bluebird-bio-inc.jpg http://www.pharmajournalist.com/evotec-and-centogene-sign-global-strategic-partnership-on-drug-discovery-projects-in-rare-genetic-diseases/ 2018-08-28T07:42:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/evotec.png http://www.pharmajournalist.com/strategia-holdings-announces-strategic-partnership-alliance-with-js-innopharm-shanghai-for-global-drug-development/ 2018-08-28T07:45:14+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Strategia-Logo.png http://www.pharmajournalist.com/medical-fair-china-2018-cutting-edge-program-for-concurrent-events-confirmed/ 2018-08-28T07:46:41+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Medical-Fair-China_Banner_Pharma-Journalist.gif https://www.pharmajournalist.com/wp-content/uploads/2018/08/ac.jpg http://www.pharmajournalist.com/adverum-biotechnologies-receives-orphan-drug-designation-for-advm-053/ 2018-08-28T07:48:04+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Adverum-Logo.png http://www.pharmajournalist.com/ptc-therapeutics-successfully-completes-acquisition-of-agilis-biotherapeutics/ 2018-08-28T07:49:30+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/PTC-therapeutics-logo.jpg http://www.pharmajournalist.com/revive-therapeutics-applies-to-fda-for-orphan-drug-designation-of-cannabidiol-for-treatment-of-liver-transplantation/ 2018-08-28T07:51:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/medical-fair-china-2018-attracts-more-than-300-exhibitors-and-covers-the-full-medical-industry-supply-chain/ 2018-08-28T07:53:11+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Medical-Fair-China_Banner_Pharma-Journalist.gif http://www.pharmajournalist.com/bertilimumab-granted-orphan-drug-designation-for-the-treatment-of-bullous-pemphigoid/ 2018-08-28T07:53:52+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Immune-Pharma-Logo.png http://www.pharmajournalist.com/enigma-biomedical-group-and-invicro-sign-a-collaboration-agreement/ 2018-08-28T07:57:55+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Enigma-Biomedical-Group-Logo.jpg http://www.pharmajournalist.com/fda-approves-first-drug-for-neurotrophic-keratitis-a-rare-eye-disease/ 2018-08-28T08:00:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/ccab-partners-with-immunobiochem-as-it-launches-new-co-development-strategy-to-advance-early-stage-biotech-companies/ 2018-08-28T08:04:05+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Immunobiochem-news-release_August-2018.jpg https://www.pharmajournalist.com/wp-content/uploads/2018/08/Immunobiochem-news-release_August-2018.jpg http://www.pharmajournalist.com/new-tablet-production-facility-in-ingelheim-centerpiece-for-global-launches/ 2018-08-28T08:08:49+00:00 https://www.pharmajournalist.com/wp-content/uploads/2018/08/Solids_Launch_Factory_ING.jpg http://www.pharmajournalist.com/novasep-custom-manufacturing-site-passes-fifth-consecutive-fda-inspection-without-483s/ 2018-08-28T08:12:37+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/NovaSep.jpg http://www.pharmajournalist.com/leo-pharma-signs-global-licensing-agreement-with-jw-pharmaceutical-for-their-novel-atopic-dermatitis-drug-candidate-jw1601/ 2018-08-28T08:14:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/leo-pharma.jpg http://www.pharmajournalist.com/agc-biologics-expands-capacity-at-copenhagen-denmark-facility/ 2018-08-28T08:16:50+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/AGC-Biologics.jpg http://www.pharmajournalist.com/medigene-and-structured-immunity-announce-collaboration-aimed-at-improving-t-cell-receptor-development/ 2018-08-28T08:21:17+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Medigene-Logo.png http://www.pharmajournalist.com/innovate-enters-into-an-agreement-with-amarex-clinical-research/ 2018-08-28T08:36:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Innovate-Biopharmaceuticals-logo.jpg http://www.pharmajournalist.com/almac-group-appoints-jonothan-cooil-as-vice-president-of-engineering-facilities-and-health-safety-environment/ 2018-08-28T08:39:40+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Jonothan-Cooil_Almac-Group.jpg https://pharmajournalist.com/wp-content/uploads/2018/08/Jonothan-Cooil_Almac-Group.jpg http://www.pharmajournalist.com/the-future-of-ocular-gene-editing-is-here/ 2018-08-29T10:51:02+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Ophthalmic-Drugs_SMi_Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/13th-annual-sell-out-conference-cold-chain-distribution-2018/ 2018-08-29T10:56:46+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Cold-Chain-Distribution-SMi-Banner-Pharma-Journalist.jpg http://www.pharmajournalist.com/medical-healthcare-and-medtech-innovations-take-centre-stage-at-asias-leading-exhibitions-medical-fair-asia-medical-manufacturing-asia-2018/ 2018-08-30T08:14:10+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Mr-Gernot-Ringling-Messe-Duesseldorf-Asia-Dr-Koh-Poh-Koon-Senior-Minister-of-State-Ministry-of-Trade-and-Industry-Mr-Philip-Kia-SPETA-at-the-Ribbon-Cutting-Ceremony.jpg https://pharmajournalist.com/wp-content/uploads/2018/08/Mr-Gernot-Ringling-Messe-Duesseldorf-Asia-Dr-Koh-Poh-Koon-Senior-Minister-of-State-Ministry-of-Trade-and-Industry-Mr-Philip-Kia-SPETA-at-the-Ribbon-Cutting-Ceremony.jpg https://www.pharmajournalist.com/wp-content/uploads/2018/08/Dr-Koh-Poh-Koon-touring-the-exhibitions.jpg http://www.pharmajournalist.com/indian-pharma-expo-ipe-2018-held-on-7th-8th-9th-august-2018-at-pragati-maidan-new-delhi/ 2018-08-30T09:21:25+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/2.jpg https://pharmajournalist.com/wp-content/uploads/2018/08/5.jpg https://pharmajournalist.com/wp-content/uploads/2018/08/4.jpg https://pharmajournalist.com/wp-content/uploads/2018/08/3.jpg https://pharmajournalist.com/wp-content/uploads/2018/08/2.jpg https://pharmajournalist.com/wp-content/uploads/2018/08/1.jpg http://www.pharmajournalist.com/regenxbio-announces-pipeline-expansion-with-rgx-181-gene-therapy-for-cln2-form-of-batten-disease/ 2018-08-31T08:05:03+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/REGENXBIO-logo.png http://www.pharmajournalist.com/sungen-pharma-establishes-injectable-division-and-form%c2%ads-manufacturing-relationship-with-gram/ 2018-08-31T08:17:43+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/SunGen-Pharma-Logo.png http://www.pharmajournalist.com/fda-approves-merck-two-new-hiv-1-medicines-delstrigo-and-pifeltro/ 2018-08-31T08:24:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/pfizer-terminates-domagrozumab-pf-06252616-clinical-studies-for-the-treatment-of-duchenne-muscular-dystrophy/ 2018-08-31T08:25:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/trovagene-announces-ec-grants-orphan-drug-designation-to-onvansertib-for-treatment-of-aml/ 2018-08-31T08:31:31+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Trovagene-logo.jpg http://www.pharmajournalist.com/polyactiva-commences-its-first-phase-i-clinical-trial-with-potential-to-improve-daily-lives-of-millions-of-glaucoma-patients/ 2018-08-31T09:21:14+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/PloyActiva-Logo.png http://www.pharmajournalist.com/longeveron-appoints-arin-maercks-chief-commercial-officer/ 2018-08-31T09:26:13+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Longeveron-Logo.png http://www.pharmajournalist.com/alnylam-receives-approval-of-onpattro-patisiran-in-europe/ 2018-08-31T09:29:18+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/alnylam-pharmaceuticals_logo.jpg http://www.pharmajournalist.com/crf-health-partners-innovative-us-biotech-with-trialmax-ecoa-solution-for-phase-iii-prostate-oncology-study/ 2018-08-31T09:33:55+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/CRF-health-Logo.jpg http://www.pharmajournalist.com/regen-biopharma-reports-success-of-its-nr2f6-small-molecule-screening-program-for-treating-autoimmune-diseases/ 2018-08-31T09:36:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Regen-BioPharma-Logo.png http://www.pharmajournalist.com/evotec-and-chdi-foundation-extend-ongoing-collaboration-to-fight-huntingtons-disease/ 2018-08-31T09:38:28+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/evotec.png http://www.pharmajournalist.com/kbi-biopharma-bvba-opens-in-leuven-belgium-offering-analytical-services-to-the-european-market/ 2018-08-31T09:40:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/kbi-biopharma.jpg http://www.pharmajournalist.com/upm-pharmaceuticals-appoints-dr-chi-chang-wung-as-director-of-analytical-development/ 2018-08-31T09:43:34+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/UPM-Pharma-Logo.jpg http://www.pharmajournalist.com/sirona-biochem-receives-500000-usd-milestone-payment-from-wanbang-biopharmaceuticals/ 2018-08-31T09:46:28+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Sirona-Biochem-Logo.jpg http://www.pharmajournalist.com/pci-expands-cold-chain-infrastructure-with-dedicated-40c-facility/ 2018-08-31T09:50:18+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/PCI-Cold-Chain-Infra.jpg https://www.pharmajournalist.com/wp-content/uploads/2018/08/PCI-Cold-Chain-Infra.jpg http://www.pharmajournalist.com/sgs-to-open-new-biopharmaceutical-testing-laboratory-in-geneva/ 2018-08-31T09:58:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/sgs-logo.jpg http://www.pharmajournalist.com/tetraphase-announces-fda-approval-of-xerava-eravacycline-for-ciai/ 2018-08-31T10:05:56+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/TETRAPHASE-Pharma-XERAVA.jpg https://www.pharmajournalist.com/wp-content/uploads/2018/08/TETRAPHASE-Pharma-XERAVA.jpg http://www.pharmajournalist.com/less-than-4-weeks-until-immuno-therapy-experts-gather-at-the-immuno-oncology-conference-this-september-in-london/ 2018-09-06T09:32:48+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Immuno-Oncology-Banner-SMi-Pharma-Journalist.jpg http://www.pharmajournalist.com/nhs-england-announces-groundbreaking-new-personalised-therapy-for-children-with-cancer/ 2018-09-07T08:17:30+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/nhs-England-Logo.jpg http://www.pharmajournalist.com/novartis-to-divest-the-sandoz-us-dermatology-business-and-generic-us-oral-solids-portfolio-to-aurobindo/ 2018-09-07T08:19:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/leo-pharma-closes-acquisition-of-bayers-prescription-dermatology-business-in-the-united-states/ 2018-09-07T08:21:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/leo-pharma.jpg http://www.pharmajournalist.com/evox-therapeutics-completes-35-5-million-series-b-financing/ 2018-09-07T08:24:06+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Evox-Therapeutics-Logo.gif http://www.pharmajournalist.com/sanofi-reaches-civil-settlement-with-us-sec/ 2018-09-07T08:27:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/sanofi.jpg http://www.pharmajournalist.com/united-therapeutics-and-mannkind-announce-collaboration-for-pulmonary-hypertension-products/ 2018-09-07T08:31:10+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/United-Therapeutics-logo.jpg http://www.pharmajournalist.com/cablivi-caplacizumab-approved-in-europe-for-adults-with-attp/ 2018-09-07T08:33:31+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/novellusdx-and-primetech-sign-an-exclusive-dealer-agreement-in-japan/ 2018-09-07T08:37:09+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Novellus-Logo.png http://www.pharmajournalist.com/amri-and-metrion-biosciences-collaborate-to-offer-ion-channel-drug-discovery-services/ 2018-09-07T08:39:21+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/AMRI-Logo.png http://www.pharmajournalist.com/gilead-and-galapagos-announce-tortuga-phase-2-study-of-filgotinib-in-ankylosing-spondylitis-achieves-primary-endpoint/ 2018-09-07T08:41:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/pfizer-receives-breakthrough-therapy-designation-from-fda-for-pf-06651600/ 2018-09-07T08:44:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/wuxi-apptec-partner-hutchison-medipharma-receives-approval-of-fruquintinib-capsules-in-china/ 2018-09-07T08:48:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/wuxi-apptec-logo.png http://www.pharmajournalist.com/atara-biotherapeutics-and-moffitt-cancer-center-announce-strategic-collaboration-to-develop-next-generation-car-t-immunotherapies/ 2018-09-07T08:59:11+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Atara-Bio_logo.png http://www.pharmajournalist.com/dzs-clinical-services-acquired-by-wdb-holdings-to-strengthen-cro-business/ 2018-09-07T09:03:15+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/DZS-Clinical-Services-Logo.jpg http://www.pharmajournalist.com/key-biologics-and-blood-centers-of-america-partner-to-advance-cell-therapy-and-regenerative-medicine/ 2018-09-07T09:33:02+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/KeyBiologics-Logo.jpg http://www.pharmajournalist.com/sgs-successfully-implements-pbmc-analysis-for-early-phase-clinical-trials/ 2018-09-07T09:35:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/sgs-logo.jpg http://www.pharmajournalist.com/adma-biologics-reports-fda-compliance-status-for-its-manufacturing-facility-has-improved/ 2018-09-07T09:38:52+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/ADMA-Biologics-Logo.png http://www.pharmajournalist.com/fda-grants-priority-review-to-mercks-sbla-for-keytruda-pembrolizumab/ 2018-09-07T09:48:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/olon-acquires-manufacturing-facility-in-india/ 2018-09-07T09:51:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/olonspa-logo.jpg http://www.pharmajournalist.com/bayer-receives-fda-approval-for-jivi-new-hemophilia-a-treatment-with-step-wise-prophylaxis-dosing-regimen/ 2018-09-07T09:54:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/bayer.jpg http://www.pharmajournalist.com/softbox-announces-launch-of-its-max-range-at-iqpc-in-philadelphia/ 2018-09-07T09:59:30+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/AEON-Softbox.png https://pharmajournalist.com/wp-content/uploads/2018/09/AEON-Softbox.png http://www.pharmajournalist.com/thrombolytic-science-initiates-phase-2-clinical-trial-of-its-novel-treatment-regimen-for-ischemic-stroke/ 2018-09-07T10:01:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical.jpg http://www.pharmajournalist.com/agenda-released-pharmaceutical-microbiology-uk-2019-announces-key-industry-speakers/ 2018-09-10T06:31:22+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Pharma-Micro-2019-Pharma-Journalist-Banner.jpg http://www.pharmajournalist.com/join-supply-chain-and-procurement-experts-from-leading-healthcare-and-medical-device-companies-this-october/ 2018-09-10T06:35:37+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Healthcare-Supply-Chain-Management-Summit-2018-Banner-Pharma-Journalist.jpg http://www.pharmajournalist.com/technology-and-innovation-drives-the-success-of-medical-fair-asia-medical-manufacturing-asia-2018/ 2018-09-11T07:20:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Medical-Fair-Asia-Banner1.png https://pharmajournalist.com/wp-content/uploads/2018/09/B47X0351.jpg https://pharmajournalist.com/wp-content/uploads/2018/09/DSCF2189.jpg https://pharmajournalist.com/wp-content/uploads/2018/09/DSCF2347.jpg http://www.pharmajournalist.com/invitation-from-carina-schey-researcher-at-university-of-groningen-and-chair-of-this-years-orphan-drugs-rare-diseases-conference/ 2018-09-11T07:36:08+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Orphan.jpg http://www.pharmajournalist.com/achieving-controlled-nucleation-during-aseptic-lyophilization/ 2018-09-13T08:24:02+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Lyophilization-USA_SMi_Pharma-Journalist.jpg http://www.pharmajournalist.com/consort-medical-signs-development-agreements-with-opiant-pharmaceuticals/ 2018-09-14T07:39:48+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Bespak.png http://www.pharmajournalist.com/tezepelumab-granted-breakthrough-therapy-designation-by-us-fda/ 2018-09-14T07:41:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/boehringer-acquires-all-viratherapeutics-shares-to-develop-next-generation-viral-based-immuno-oncology-therapies/ 2018-09-14T07:53:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/paragon-bioteck-reformulated-freshkote-prompting-eyevance-acquisition/ 2018-09-14T07:57:10+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Paragon-BioTeck-Logo.png http://www.pharmajournalist.com/casma-therapeutics-announces-partnership-with-fondazione-telethon/ 2018-09-14T08:00:51+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Casma-Therapeutics-Logo.jpg http://www.pharmajournalist.com/eyevance-acquires-freshkote-lubricant-eye-drop-family-of-products-from-focus-laboratories/ 2018-09-14T08:04:41+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Opthalmic-Eyevance-Pharma.jpg http://www.pharmajournalist.com/wuxi-biologics-and-inhibrx-enter-an-exclusive-partnership-for-gmp-manufacturing/ 2018-09-14T08:13:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/wuxi-biologics-logo.png http://www.pharmajournalist.com/thermo-fisher-scientific-to-acquire-advanced-bioprocessing-business-from-bd/ 2018-09-14T08:15:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/thermo-fisher-scientific.jpg http://www.pharmajournalist.com/scilex-presents-ztlido-data-on-superior-adhesion-over-lidocaine-patch-formulation/ 2018-09-14T08:18:05+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Scilex-Pharma-Logo.png http://www.pharmajournalist.com/recipharm-connects-to-european-hub-for-serialisation-compliance/ 2018-09-14T08:21:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/recipharm.jpg http://www.pharmajournalist.com/pmi-biopharma-solutions-launches-research-and-manufacturing-facilities/ 2018-09-14T08:24:53+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/PMI-BioPharma-Solutions.jpg https://www.pharmajournalist.com/wp-content/uploads/2018/09/PMI-BioPharma-Solutions.jpg http://www.pharmajournalist.com/sanofi-to-refocus-two-global-business-units/ 2018-09-14T08:28:30+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/pall-corporation-and-aetos-biologics-partner-to-deliver-biosimilar-manufacturing-solutions/ 2018-09-14T08:32:46+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Pall-Corporation-Logo.jpg http://www.pharmajournalist.com/cambrex-completes-acquisition-of-halo-pharma/ 2018-09-14T08:34:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/cambrex.jpeg http://www.pharmajournalist.com/fda-assigns-pdufa-date-to-portola-pharmaceuticals-prior-approval-supplement-for-the-large-scale-generation-2-andexxa-process/ 2018-09-14T08:36:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/pci-pharma-services-to-acquire-sherpa-clinical-packaging/ 2018-09-14T08:40:03+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Sherpa-Clinical-Packaging.jpg https://www.pharmajournalist.com/wp-content/uploads/2018/09/Sherpa-Clinical-Packaging.jpg http://www.pharmajournalist.com/the-carlyle-group-acquires-significant-minority-stake-in-ambio/ 2018-09-14T08:46:31+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/carlyle-group-logo.jpg http://www.pharmajournalist.com/cdc-awards-biocryst-35-million-rapivab-contract-for-strategic-national-stockpile/ 2018-09-14T08:50:15+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/bioCryst-Logo.jpg http://www.pharmajournalist.com/epimab-biotherapeutics-announces-ind-filing-for-emb01-in-china-and-the-us/ 2018-09-14T08:54:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/drug.jpg http://www.pharmajournalist.com/the-20-start-ups-leading-the-way-in-microbiome-based-skincare/ 2018-09-17T07:41:23+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Skin-Asia-Banner-300x250_PharmaJournalist.jpg http://www.pharmajournalist.com/antibiotic-class-emerges-through-digestive-enzyme-find-out-more-at-3rd-annual-superbugs-and-superdrugs-usa-conference/ 2018-09-17T07:58:18+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Superbugs-Superdrugs-USA_SMi_Pharma-Journalist.jpg http://www.pharmajournalist.com/cardurion-pharmaceuticals-announces-initiation-of-phase-1-study-of-crd-733/ 2018-09-21T06:54:48+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Cardurion-Pharma-Logo.png http://www.pharmajournalist.com/emergex-enters-into-mou-with-brazils-fiocruz-to-develop-novel-vaccines-against-viral-diseases/ 2018-09-21T06:57:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/drug.jpg http://www.pharmajournalist.com/adverum-biotechnologies-receives-fast-track-designation-for-advm-022-gene-therapy-for-the-treatment-of-wamd/ 2018-09-21T07:00:03+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Adverum-Logo.png http://www.pharmajournalist.com/propanc-biopharma-enters-into-research-collaboration-agreement-with-the-university-of-jaen/ 2018-09-21T07:03:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/valeo-pharma-and-besins-healthcare-announce-partnership-for-utrogestan-in-canada/ 2018-09-21T07:06:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical.jpg http://www.pharmajournalist.com/morphosys-and-leo-pharma-expand-strategic-alliance-to-develop-peptide-derived-therapeutics/ 2018-09-21T07:08:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/leo-pharma.jpg http://www.pharmajournalist.com/crispr-therapeutics-and-viacyte-announce-strategic-collaboration-to-develop-gene-edited-stem-cell-derived-therapy-for-diabetes/ 2018-09-21T07:12:10+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Viacyte-Logo.png http://www.pharmajournalist.com/samumed-and-united-therapeutics-announce-north-american-license-agreement-for-samumeds-ipf-drug-candidate/ 2018-09-21T07:15:19+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Samumed-Logo.png http://www.pharmajournalist.com/halozyme-announces-approval-of-subcutaneous-formulation-of-trastuzumab-herceptin-in-canada/ 2018-09-21T07:17:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.png http://www.pharmajournalist.com/allergan-to-acquire-bonti-adding-new-neurotoxin-programs-to-medical-aesthetics-pipeline/ 2018-09-21T07:18:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/allergan.jpg http://www.pharmajournalist.com/abzena-announces-a-research-and-licence-agreement-with-tmunity-therapeutics-a-t-cell-engineering-company/ 2018-09-21T07:21:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical.jpg http://www.pharmajournalist.com/just-biotherapeutics-announces-product-development-and-manufacturing-agreement-with-pandion-therapeutics/ 2018-09-21T07:24:54+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Just-Biotherapeutics-Logo.jpg http://www.pharmajournalist.com/aphena-expands-dea-packaging-capabilities-in-maryland-and-tennessee/ 2018-09-21T07:29:33+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Aphena-Pharma-Solutions-Logo.jpg http://www.pharmajournalist.com/avista-pharma-solutions-expands-service-offerings-in-new-england/ 2018-09-21T07:32:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Avista-Pharma-Solutions.jpg http://www.pharmajournalist.com/thermo-fisher-scientific-to-launch-global-customer-solution-centers/ 2018-09-21T07:35:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/thermo-fisher-scientific.jpg http://www.pharmajournalist.com/lonza-expands-ibex-solutions-to-offer-complete-product-lifecycle-management-in-one-location/ 2018-09-21T07:37:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/lonza.jpg http://www.pharmajournalist.com/molecular-templates-announces-agreement-with-takeda-for-the-joint-development-of-a-protein-based-oncology-therapy/ 2018-09-21T07:40:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/zosano-pharma-completes-manufacture-of-m207-registration-batches/ 2018-09-21T07:42:34+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Zosana-Pharma-Logo.jpg http://www.pharmajournalist.com/neurimmune-achieves-milestone-in-collaboration-with-ono-pharmaceutical/ 2018-09-21T07:44:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/neurimmune-image.jpg http://www.pharmajournalist.com/fasenra-shows-consistent-safety-and-sustained-efficacy-in-long-term-phase-iii-bora-trial-in-severe-eosinophilic-asthma/ 2018-09-21T07:47:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/bia-separations-expands-with-new-upstream-processing-facility/ 2018-09-21T07:52:14+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/BIA-Separations.jpg https://www.pharmajournalist.com/wp-content/uploads/2018/09/BIA-Separations.jpg http://www.pharmajournalist.com/evotec-and-almirall-enter-into-research-collaboration-in-the-field-of-dermatological-diseases/ 2018-09-21T07:53:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/evotec.png http://www.pharmajournalist.com/beigene-selects-ge-healthcares-off-the-shelf-biologics-factory-to-boost-its-manufacturing-capacity-for-cancer-drugs/ 2018-09-21T08:06:35+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/BeiGene-KUBio.jpg https://www.pharmajournalist.com/wp-content/uploads/2018/09/BeiGene-KUBio.jpg http://www.pharmajournalist.com/roivant-launches-respivant-sciences-to-develop-innovative-therapeutics-for-respiratory-diseases/ 2018-09-21T08:16:24+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Roivant_Logo.png http://www.pharmajournalist.com/atomwise-enters-into-an-evaluation-agreement-with-pfizer/ 2018-09-21T08:17:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/full-agenda-released-for-pre-filled-syringes-injectable-drug-devices-europe/ 2018-09-26T11:04:04+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Pre-Filled-Syringes-Europe_Pharma-Journalist.jpg https://pharmajournalist.com/wp-content/uploads/2018/09/P-272-PFS-600x400.jpg http://www.pharmajournalist.com/smis-11th-annual-social-media-in-pharma-returns-to-london-this-january-2019/ 2018-09-26T11:10:11+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Social-Media-in-Pharmaceutical-Industry-Banner-Pharma-Journalist.jpg http://www.pharmajournalist.com/smis-10th-annual-rna-therapeutics-returns-to-london-this-february-2019/ 2018-09-27T07:35:30+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/RNA-Therapeutics-Banner-Pharma-Journalist.jpg https://www.pharmajournalist.com/wp-content/uploads/2018/09/RNA-Therapeutics-Banner-Pharma-Journalist.jpg http://www.pharmajournalist.com/smi-release-speaker-interview-for-anita-burrell-speaking-at-biosimilars-usa-conference/ 2018-09-27T14:55:14+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/300x250.jpg http://www.pharmajournalist.com/seattle-genetics-announces-adcetris-brentuximab-vedotin-approval-in-japan-for-frontline-hodgkin-lymphoma/ 2018-09-28T09:00:05+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Seattle-Genetics.jpg http://www.pharmajournalist.com/mebias-discovery-receives-grant-from-nida-to-advance-its-signaling-pathway-selective-mu-opioid-receptor-drug-candidate/ 2018-09-28T09:04:25+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/MEBIAS-DISCOVERY-LOGO.png http://www.pharmajournalist.com/tris-pharma-expands-adhd-portfolio-with-acquisition-of-nextwave-pharmaceuticals/ 2018-09-28T09:07:47+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Tris-Pharma.jpg http://www.pharmajournalist.com/peptidream-announces-drug-discovery-and-development-agreement-with-santen-pharmaceutical/ 2018-09-28T09:10:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/peptiDream-logo.jpg http://www.pharmajournalist.com/alexion-to-acquire-syntimmune/ 2018-09-28T09:12:16+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Alexion-Pharma-Logo.png http://www.pharmajournalist.com/selexis-sa-and-hoba-therapeutics-team-up-to-advance-hobas-investigational-neuropathic-pain-treatment-into-the-clinic/ 2018-09-28T09:14:13+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Selexis-Cell-Line-Development.jpg http://www.pharmajournalist.com/dova-pharmaceuticals-and-salix-enter-into-exclusive-co-promotion-agreement-for-doptelet-avatrombopag/ 2018-09-28T09:18:12+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Dova-Pharmaceuticals-Logo.png http://www.pharmajournalist.com/cerecor-to-acquire-ichorion-therapeutics/ 2018-09-28T09:22:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/pharmablock-appoints-dr-shijie-zhang-as-chief-technology-officer/ 2018-09-28T09:26:10+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/PharmaBlock-Logo.png http://www.pharmajournalist.com/agc-biologics-adds-mammalian-production-capacity-in-japan/ 2018-09-28T09:28:53+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/AGC-Biologics.jpg http://www.pharmajournalist.com/celltrion-signs-incubation-agreement-with-emory-university-for-development-of-new-drugs-for-atherosclerosis/ 2018-09-28T09:34:42+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/celltrion-Image.png http://www.pharmajournalist.com/egypts-ibnsina-pharma-drives-agility-with-infor/ 2018-09-28T09:41:05+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/infor-logo.png http://www.pharmajournalist.com/gilead-to-launch-authorized-generics-of-epclusa-and-harvoni-for-the-treatment-of-chronic-hepatitis-c/ 2018-09-28T09:43:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/fda-grants-myelo-therapeutics-orphan-drug-designation-for-myelo001-as-treatment-for-acute-radiation-syndrome/ 2018-09-28T09:49:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/bydureon-receives-positive-eu-chmp-opinion-for-exscel-cardiovascular-outcomes-data/ 2018-09-28T09:50:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/european-commission-approves-imfinzi-for-locally-advanced-unresectable-nsclc/ 2018-09-28T09:52:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/sarepta-announces-clinical-hold-lifted-for-its-duchenne-muscular-dystrophy-micro-dystrophin-gene-therapy-program/ 2018-09-28T09:56:40+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Sarepta-Therapeutics.jpg http://www.pharmajournalist.com/enesi-pharma-and-wrair-to-develop-vaccine-for-shigella-infection/ 2018-09-28T10:26:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/drug.jpg http://www.pharmajournalist.com/17th-pharmacovigilance-2018/ 2018-10-01T12:26:42+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/17th-PV-2018-300x250px-size-banner.jpg http://www.pharmajournalist.com/exclusive-speaker-interview-with-brent-cezairliyan-for-smis-superbugs-superdrugs-usa/ 2018-10-02T05:54:24+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Superbugs-Superdrugs-USA_SMi_Pharma-Journalist.jpg http://www.pharmajournalist.com/pharma-giants-collaboration-accelerates-access-to-rare-disease-treatment-hear-more-at-orphan-drugs-rare-diseases-2018/ 2018-10-03T07:05:55+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Orphan.jpg http://www.pharmajournalist.com/vertex-announces-access-contract-in-denmark-for-current-and-future-cystic-fibrosis-medicines/ 2018-10-05T08:15:38+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Vertex.jpg http://www.pharmajournalist.com/japan-mhlw-grants-orphan-drug-designation-to-axicabtagene-ciloleucel-for-treatment-of-certain-types-of-b-cell-lymphoma/ 2018-10-05T08:18:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/Daiichi-Pharma.jpg http://www.pharmajournalist.com/kite-partners-with-hifibio-therapeutics-for-tcr-based-cancer-therapies/ 2018-10-05T08:21:11+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Kite-Gilead-Company.png http://www.pharmajournalist.com/novartis-licenses-three-novel-anti-infective-programs-to-boston-pharmaceuticals/ 2018-10-05T08:22:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/merck-and-dragonfly-partner-to-develop-cancer-immunotherapies/ 2018-10-05T08:24:57+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Dragonfly-Therapeutics-logo.png http://www.pharmajournalist.com/recipharm-completes-acquisition-of-sanofi-inhalation-contract-manufacturing-business/ 2018-10-05T08:26:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/recipharm.jpg http://www.pharmajournalist.com/innovent-receives-an-approval-from-fda-to-initiate-clinical-trials-for-its-anti-cd47-monoclonal-antibody-ibi-188/ 2018-10-05T08:31:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.png http://www.pharmajournalist.com/fda-approves-genentechs-xolair-omalizumab-prefilled-syringe-formulation/ 2018-10-05T08:33:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/cytosen-and-kbi-enter-into-strategic-partnership-to-manufacture-nk-cells-and-nanoparticles/ 2018-10-05T08:40:28+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/kbi-biopharma.jpg http://www.pharmajournalist.com/aptar-pharma-launches-purehale-a-new-portable-and-ready-to-use-upper-respiratory-drug-delivery-solution/ 2018-10-05T08:44:23+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/PureHale-Aptar-Pharma.jpg https://www.pharmajournalist.com/wp-content/uploads/2018/10/PureHale-Aptar-Pharma.jpg http://www.pharmajournalist.com/evonik-launches-eudragit-fl-30-d-55-an-advanced-combination-polymer-that-sets-a-new-benchmark-for-enteric-coatings/ 2018-10-05T08:47:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Evonik.jpg http://www.pharmajournalist.com/evotec-signs-agreement-with-sanofi-to-advance-early-stage-academic-research-into-novel-therapeutic-candidates/ 2018-10-05T08:50:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/evotec.png http://www.pharmajournalist.com/horizon-enters-into-license-agreement-with-cytovance-for-hd-biop3-suspension-adapted-gs-null-cho-k1-cells/ 2018-10-05T08:53:32+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/horizon-discovery-logo.png http://www.pharmajournalist.com/alnylam-reports-updated-positive-results-from-phase-1-2-study-of-lumasiran-in-patients-with-primary-hyperoxaluria-type-1/ 2018-10-05T09:44:31+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/alnylam-pharmaceuticals_logo.jpg http://www.pharmajournalist.com/dr-reddys-laboratories-announces-the-sale-of-its-antibiotic-manufacturing-site-and-its-related-assets-in-bristol-tennessee/ 2018-10-05T09:47:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/dr-reddy-logo.png http://www.pharmajournalist.com/chugais-hemlibra-receives-regulatory-approval-from-fda-for-hemophilia-a-without-inhibitors/ 2018-10-05T09:49:48+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/chugai-logo.png http://www.pharmajournalist.com/prana-biotechnology-pre-clinical-evidence-demonstrates-pbt434-as-a-potential-treatment-for-msa/ 2018-10-05T09:53:06+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Prana-Biotechnology-Logo.png http://www.pharmajournalist.com/therapure-biomanufacturing-announces-u-s-fda-approval-for-manufacturing-of-its-partner-insmeds-arikayce/ 2018-10-05T09:59:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/moffitt-cancer-center-to-chair-7th-lung-cancer-screening-continuum-of-care/ 2018-10-05T13:13:05+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/LCS7-300x250.jpg http://www.pharmajournalist.com/an-interview-with-alexander-zuern-device-testing-manager-from-novartis-ahead-of-pre-filled-syringes-europe-2019/ 2018-10-09T09:57:31+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/P-272-PFS-375x375.jpg https://pharmajournalist.com/wp-content/uploads/2018/10/P-272-PFS-375x375.jpg http://www.pharmajournalist.com/janssen-submits-european-marketing-authorisation-application-for-esketamine-nasal-spray/ 2018-10-12T07:35:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/Janssen.jpg http://www.pharmajournalist.com/ionis-enters-new-collaboration-with-partner-to-develop-ionis-fb-l-rx-for-complement-mediated-diseases/ 2018-10-12T07:40:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/ionis-pharma1.jpg http://www.pharmajournalist.com/wave-life-sciences-to-develop-programs-in-rare-genetic-eye-diseases/ 2018-10-12T07:43:31+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Wave-Life-Sciences-Logo.png http://www.pharmajournalist.com/the-despiad-clinical-trial-testing-a-new-approach-to-treatment-of-alzheimers-disease/ 2018-10-12T07:44:48+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/alzheimers-disease.jpg http://www.pharmajournalist.com/amicus-therapeutics-enters-rd-collaboration-with-university-of-pennsylvania-to-develop-aav-gene-therapies/ 2018-10-12T07:48:54+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Amicus-Therapeutics-Logo.jpg http://www.pharmajournalist.com/fda-approves-roches-hemlibra-for-haemophilia-a-without-factor-viii-inhibitors/ 2018-10-12T07:57:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/bms-and-compugen-announce-clinical-collaboration-to-evaluate-therapeutic-regimen-in-advanced-solid-tumors/ 2018-10-12T08:06:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/mundipharma-strengthens-position-as-a-leader-in-biosimilars-with-acquisition-of-development-company-cinfa-biotech/ 2018-10-12T08:09:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Mundipharma-Logo.png http://www.pharmajournalist.com/roslinct-and-reprocell-awarded-1-2-million-project-from-innovate-uk-for-clinical-grade-stem-cell-production/ 2018-10-12T08:11:25+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/RoslinCT-logo.jpg http://www.pharmajournalist.com/unicar-therapy-and-terumo-bct-collaborate-to-advance-car-t-cell-therapies-and-create-a-shanghai-china-center-of-excellence/ 2018-10-12T08:15:57+00:00 https://www.pharmajournalist.com/wp-content/uploads/2018/10/Quantum-Cell-Expansion-System.png http://www.pharmajournalist.com/neurocrine-and-jnana-enter-strategic-collaboration-to-discover-novel-medicines/ 2018-10-12T08:18:33+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Neurocrine-Biosciences.jpg http://www.pharmajournalist.com/novan-expands-nitric-oxide-dermatology-business-partnership-with-sato-in-japan/ 2018-10-12T08:21:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/sarepta-enters-into-manufacturing-partnership-with-paragon-bioservices/ 2018-10-12T08:23:12+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Sarepta-Therapeutics.jpg http://www.pharmajournalist.com/noramco-adds-capacity-and-dual-sources-of-supply-for-cannabinoids/ 2018-10-12T08:26:49+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/noramco-logo.png http://www.pharmajournalist.com/almac-group-invests-to-expand-its-existing-north-carolina-facility/ 2018-10-12T08:29:27+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Almac-Group-North-Carolina-Facility.jpg https://www.pharmajournalist.com/wp-content/uploads/2018/10/Almac-Group-North-Carolina-Facility.jpg http://www.pharmajournalist.com/usp-launches-new-program-to-support-quality-in-pharmaceutical-development/ 2018-10-12T08:32:22+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/USP-Logo.png http://www.pharmajournalist.com/allergan-joins-trinetx-to-access-network-of-real-world-data-for-clinical-research/ 2018-10-12T08:34:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/allergan.jpg http://www.pharmajournalist.com/recipharm-releases-first-serialised-products-to-europe/ 2018-10-12T08:37:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/recipharm.jpg http://www.pharmajournalist.com/marina-biotech-announces-name-change-to-adhera-therapeutics/ 2018-10-12T08:39:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Marina-Biotech-Logo.jpg http://www.pharmajournalist.com/novartis-announces-fda-and-ema-filing-acceptance-of-siponimod/ 2018-10-12T08:45:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/biogen-and-samsung-bioepis-announce-european-launch-of-imraldi-adalimumab/ 2018-10-19T11:08:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Biogen-logo.jpg http://www.pharmajournalist.com/fda-grants-lynparza-olaparib-orphan-drug-designation-for-pancreatic-cancer/ 2018-10-19T11:12:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/nih-awards-allele-with-grant-for-the-development-of-nanoantibody-therapies-for-treating-sepsis/ 2018-10-19T11:14:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/sandoz-announces-global-resolution-of-biosimilar-adalimumab-patent-disputes-securing-patient-access/ 2018-10-19T11:17:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/sandoz.jpg http://www.pharmajournalist.com/foundation-medicine-announces-strategic-collaboration-with-major-pharmaceutical-company/ 2018-10-19T11:37:21+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Foundation-Medical-Logo.jpg http://www.pharmajournalist.com/endocyte-enters-into-agreement-to-be-acquired-by-novartis-ag-for-2-1-billion/ 2018-10-19T11:39:42+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/endocyte-logo.jpg http://www.pharmajournalist.com/meiragtx-enters-collaboration-with-johnson-johnson-innovation-to-develop-regulatable-gene-therapy-treatment/ 2018-10-19T11:41:05+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/MeiraGTx-Logo.jpg http://www.pharmajournalist.com/novan-extends-technical-production-capacity-and-reaches-agreement-with-orion-corporation/ 2018-10-19T11:43:32+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Novan-Logo.jpg http://www.pharmajournalist.com/hifibio-therapeutics-acquires-h-immune-therapeutics/ 2018-10-19T11:47:32+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/HiFiBiO-Logo.png http://www.pharmajournalist.com/telix-and-anmi-expand-psma-imaging-partnership/ 2018-10-19T11:55:48+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Telix-Pharmaceuticals-Logo.jpg http://www.pharmajournalist.com/idt-biologika-awarded-10-year-nih-contract-to-manufacture-vaccines-and-biologics-for-infectious-diseases/ 2018-10-19T12:00:26+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/IDT-Logo.jpg http://www.pharmajournalist.com/iovance-and-masthercell-announce-new-manufacturing-services-agreement-in-europe/ 2018-10-19T12:03:07+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Iovance-Biotherapeutics-Logo.jpg http://www.pharmajournalist.com/hovione-increases-production-capacity/ 2018-10-19T12:05:58+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Hovione.jpg http://www.pharmajournalist.com/kala-pharma-submits-new-drug-application-to-fda-for-kpi-121-0-25-for-dry-eye-disease/ 2018-10-19T12:10:23+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/kala-Pharmaceuticals-Logo.png http://www.pharmajournalist.com/fda-grants-lynparza-orphan-drug-designation-for-pancreatic-cancer/ 2018-10-19T12:12:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/daiichi-sankyo-launches-phase-1-trial-of-ds-1205-in-egfr-mutated-nsclc/ 2018-10-19T12:15:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/Daiichi-Pharma.jpg http://www.pharmajournalist.com/maat-pharma-announces-first-patient-dosed-in-phase-2-clinical-trial-of-lead-product-maat013/ 2018-10-19T12:18:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.png http://www.pharmajournalist.com/abbvie-and-morphic-therapeutic-announce-collaboration-targeting-fibrotic-diseases/ 2018-10-19T12:19:49+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/aclaris-therapeutics-to-acquire-worldwide-rights-to-rhofade-from-allergan/ 2018-10-19T12:21:27+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Aclaris-therapeutics.jpg http://www.pharmajournalist.com/apceth-biopharma-presents-positive-data-demonstrating-efficacy-of-apceth-201-in-preclinial-models-of-acute-gvhd/ 2018-10-19T12:25:28+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/apceth-logo.png http://www.pharmajournalist.com/amneal-announces-approval-of-carmustine-for-injection-usp-100-mg-vial-preparing-for-launch/ 2018-10-19T12:29:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/drug.jpg http://www.pharmajournalist.com/ebook-datax-guide-to-how-machine-learning-will-transform-the-pharmaceutical-supply-chain/ 2018-10-25T12:37:05+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/DataX-Logo.jpg http://www.pharmajournalist.com/bain-capital-and-pfizer-create-cerevel-therapeutics-new-cns-company/ 2018-10-25T14:28:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/astrazeneca-and-innate-pharma-extend-oncology-alliance/ 2018-10-25T14:29:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/fda-approves-asthma-indication-for-dupixent-dupilumab/ 2018-10-25T14:33:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/sanofi.jpg http://www.pharmajournalist.com/pfizer-presents-overall-survival-data-from-paloma-3-trial-of-ibrance-palbociclib/ 2018-10-25T14:35:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/zymeworks-and-leo-pharma-enter-into-bispecific-antibody-licensing-and-research-collaboration/ 2018-10-25T14:37:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/leo-pharma.jpg http://www.pharmajournalist.com/mesoblast-expands-partnership-with-jcr-for-treatment-of-wound-healing-in-epidermolysis-bullosa/ 2018-10-25T14:41:17+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/mesoblast-logo.png http://www.pharmajournalist.com/canbridge-and-wuxi-biologics-enter-into-strategic-partnership-for-rare-disease-therapeutics/ 2018-10-25T14:43:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/two-labs-acquires-pennside-partners-ltd/ 2018-10-25T14:46:13+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/TwoLabs-Logo.png http://www.pharmajournalist.com/purdue-pharma-enters-into-exclusive-option-agreement-to-acquire-spinethera-and-its-non-opioid-product/ 2018-10-25T14:58:22+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Purdue-Pharma.jpg http://www.pharmajournalist.com/lsk-biopharma-and-jiangsu-hengrui-medicine-announce-global-clinical-collaboration/ 2018-10-25T15:01:20+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/LSKbiopharma-logo.jpg http://www.pharmajournalist.com/abbvie-to-assume-full-development-and-commercial-control-of-cystic-fibrosis-research-program/ 2018-10-25T15:05:09+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/manufacturing-licence-restriction-at-recipharm-ltd-ashton-u-lyne-uk-facility/ 2018-10-25T15:06:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/recipharm.jpg http://www.pharmajournalist.com/vetter-further-expands-secondary-packaging/ 2018-10-25T15:09:13+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Secondary-packaging-line-Vetter.jpg https://pharmajournalist.com/wp-content/uploads/2018/10/Secondary-packaging-line-Vetter.jpg http://www.pharmajournalist.com/orgenesis-announces-collaboration-with-hemogenyx-to-develop-blood-stem-cell-replacement-product/ 2018-10-25T15:11:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/sgs-introduces-new-in-vitro-toxicology-testing-at-its-mississauga-canada-laboratory/ 2018-10-25T15:12:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/sgs-logo.jpg http://www.pharmajournalist.com/compass-pathways-receives-fda-breakthrough-therapy-designation/ 2018-10-25T15:14:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/casi-pharmaceuticals-acquires-hbv-anda-from-laurus-labs-limited/ 2018-10-25T15:16:14+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/casi-pharmaceuticals-logo.png http://www.pharmajournalist.com/velesco-pharma-expands-acquiring-a-new-research-and-cgmp-analytical-laboratory/ 2018-10-25T15:18:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/almac-group-announces-successful-hsa-inspection-of-singapore-facility/ 2018-10-25T15:21:41+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/HSA-Inspection_Almac-Group.jpg https://www.pharmajournalist.com/wp-content/uploads/2018/10/HSA-Inspection_Almac-Group.jpg http://www.pharmajournalist.com/fsd-pharma-signs-binding-loi-to-acquire-therapix-biosciences/ 2018-10-25T15:24:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/vertex-gets-chmp-positive-opinion-for-kalydeco-to-treat-cf-in-young-children/ 2018-10-25T15:26:54+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/vertex-pharma-logo.png http://www.pharmajournalist.com/registration-officially-opens-for-the-21st-annual-superbugs-superdrugs-conference/ 2018-11-01T12:26:45+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Superbugs-Superdrugs-2018-Banner-Pharma-Journalist.jpg http://www.pharmajournalist.com/abbvie-receives-ec-approval-of-venclyxto-and-rituximab-to-treat-cll/ 2018-11-02T02:34:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/abbvie.jpg http://www.pharmajournalist.com/novo-nordisk-expands-its-biopharm-business-with-the-acquisition-of-the-us-and-canadian-rights-to-macrilen-tm/ 2018-11-02T02:36:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/novo-nordisk-logo.jpg http://www.pharmajournalist.com/fda-approves-invokana-canagliflozin-to-reduce-the-risk-of-cv-events/ 2018-11-02T02:42:25+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Janssen-Pharma-Logo.jpg http://www.pharmajournalist.com/astrazeneca-signs-922m-licensing-deal-with-grunenthal/ 2018-11-02T02:46:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/lilly-and-dicerna-announce-rnai-licensing-and-research-collaboration/ 2018-11-02T02:49:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/novartis-announces-clinical-collaboration-with-pfizer-to-advance-the-treatment-of-nash/ 2018-11-02T02:51:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/gilead-and-tango-announce-strategic-collaboration-to-develop-next-generation-targeted-immuno-oncology-therapies/ 2018-11-02T03:01:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/puration-inc-confirms-cannabis-pharmaceutical-partnership-developments-with-kali-and-nouveau/ 2018-11-02T03:06:28+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/distributed-bio-announces-collaboration-with-h3-biomedicine/ 2018-11-02T03:08:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/h3-Biomedicine.jpg http://www.pharmajournalist.com/rigel-enters-collaboration-and-license-agreement-with-kissei-pharmaceutical/ 2018-11-02T03:11:19+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Rigel-Pharma-Logo.png http://www.pharmajournalist.com/bioasis-announces-xb3-platform-technology-licensing-agreement-with-prothena/ 2018-11-02T03:15:49+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/bioasis-Logo.jpg http://www.pharmajournalist.com/canntrust-expands-global-reach-and-access-to-asia-pacific-region-as-cannatreks-cornerstone-investor/ 2018-11-02T03:21:57+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/CannTrust-Logo.jpg http://www.pharmajournalist.com/pmi-biopharma-solutions-announces-appointment-of-david-sunseri-phd-as-ceo/ 2018-11-02T03:30:22+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/David-Sunseri.jpg https://pharmajournalist.com/wp-content/uploads/2018/11/David-Sunseri.jpg http://www.pharmajournalist.com/ppd-strengthens-drug-development-expertise-with-new-therapeutic-area-professionals/ 2018-11-02T03:32:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/PPD-office_wikipedia.jpg http://www.pharmajournalist.com/denali-therapeutics-announces-broad-collaboration-with-sanofi/ 2018-11-02T03:33:47+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/genesis-biotechnology-group-announces-partnership-with-yale-university/ 2018-11-02T03:36:05+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/avance-biosciences-completes-successful-fda-inspection/ 2018-11-02T03:37:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/corerx-completes-installation-of-the-optel-line-master-serialization-and-aggregation-system/ 2018-11-02T03:42:52+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/CoreRxLogo.png http://www.pharmajournalist.com/lonza-acquires-a-controlling-stake-in-octane-biotech-to-further-develop-cocoon-tm-autologous-technology/ 2018-11-02T03:45:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/lonza.jpg http://www.pharmajournalist.com/charles-river-and-distributed-bio-enter-exclusive-partnership/ 2018-11-02T06:10:57+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Charles-River.jpeg http://www.pharmajournalist.com/alcami-helps-medicines-development-for-global-health-secure-fda-approval-of-moxidectin-for-river-blindness/ 2018-11-02T06:11:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/alcami-logo.jpg http://www.pharmajournalist.com/aerie-pharmaceuticals-establishes-gmp-print-production-facility-in-an-expanded-global-headquarters/ 2018-11-02T06:11:15+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Aerie-Pharmaceuticals.jpg http://www.pharmajournalist.com/thermo-fisher-scientific-completes-acquisition-of-advanced-bioprocessing-from-bd/ 2018-11-02T06:11:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/thermo-fisher-scientific.jpg http://www.pharmajournalist.com/johnson-johnson-unveils-new-vaccines-launch-facility-to-support-global-rollout-of-novel-vaccines/ 2018-11-02T06:11:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Johnson-Johnson-Logo.png http://www.pharmajournalist.com/social-media-in-the-pharma-industry-are-you-listening/ 2018-11-05T08:25:59+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Social-Media-in-Pharmaceutical-Industry-Banner-Pharma-Journalist.jpg http://www.pharmajournalist.com/smis-3d-cell-culture-announces-key-industry-speakers-and-agenda-released/ 2018-11-06T16:29:38+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/3D-Cell-Culture-Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/final-reminder-1-week-until-smis-lyophilization-usa/ 2018-11-08T10:46:14+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Lyophilization-USA_SMi_Pharma-Journalist.jpg http://www.pharmajournalist.com/amgen-and-provention-bio-announce-co-development-collaboration-in-celiac-disease/ 2018-11-09T07:45:38+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/sementis-and-enesi-pharma-partner-to-develop-needle-free-vaccines/ 2018-11-09T07:48:53+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/ENESI_LAB-SHOTS.jpg http://www.pharmajournalist.com/hikma-announces-global-agreement-with-vectura-to-develop-generic-versions-of-gsks-ellipta-portfolio/ 2018-11-09T07:56:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/biotime-and-asterias-enter-into-definitive-merger-agreement-to-create-leading-cell-therapy-company/ 2018-11-09T08:00:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/guided-therapeutics-announces-extension-of-distribution-agreement-for-eastern-europe-and-russia/ 2018-11-09T08:10:42+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Guided-Therapeutics-Logo.jpg http://www.pharmajournalist.com/brooklyn-immunotherapeutics-acquires-irx-therapeutics/ 2018-11-09T08:22:47+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Brooklyn-Immunotherapeutics-logo.jpg http://www.pharmajournalist.com/lilly-and-nextcure-announce-collaboration-to-discover-and-develop-novel-immuno-oncology-medicines/ 2018-11-09T08:32:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/numedii-announces-research-collaboration-with-leading-academic-research-institution/ 2018-11-09T08:36:21+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/numediii-logo.jpg http://www.pharmajournalist.com/fda-approves-first-drug-using-the-recombinant-factor-c-assay-for-endotoxin-testing/ 2018-11-09T08:43:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/lonza.jpg http://www.pharmajournalist.com/concept-life-sciences-extends-glp-accreditation-to-support-regulatory-studies-to-support-pharma-and-biotech-industries/ 2018-11-09T08:54:03+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Concept-Life-Sciences-logo.png http://www.pharmajournalist.com/altasciences-completes-bioanalytical-laboratory-expansion/ 2018-11-09T08:55:46+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Altasciences-Logo.png http://www.pharmajournalist.com/milliporesigma-launches-biocontinuum-platform-for-next-generation-process-improvements/ 2018-11-09T09:01:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/MilliporeSigma.jpg http://www.pharmajournalist.com/samsung-biologics-closes-an-asset-transfer-deal-with-biogen/ 2018-11-09T09:04:42+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Samsung-BioLogics.jpg http://www.pharmajournalist.com/lonza-releases-first-2000l-single-use-bioreactor-sub-batch-from-singapore-for-tracon-pharmaceuticals/ 2018-11-09T09:07:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/lonza.jpg http://www.pharmajournalist.com/glenmark-plans-to-launch-phase-1-trial-in-solid-tumors-for-gbr-1342/ 2018-11-09T09:27:09+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Glenmark-Pharma-Image.jpg http://www.pharmajournalist.com/divestment-of-rights-to-alvesco-omnaris-and-zetonna-to-covis-pharma/ 2018-11-09T09:31:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/seattle-genetics-submits-supplemental-biologics-license-application-for-adcetris/ 2018-11-09T09:34:36+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Seattle-Genetics.jpg http://www.pharmajournalist.com/genkyotex-meets-both-primary-and-secondary-interim-efficacy-endpoints-in-phase-2-trial-of-gkt831-in-primary-biliary-cholangitis/ 2018-11-09T09:36:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.jpg http://www.pharmajournalist.com/bms-infinity-to-assess-opdivo-ipi-549-combo-in-urothelial-cancer/ 2018-11-09T09:39:48+00:00 http://www.pharmajournalist.com/quotient-sciences-significantly-expands-formulation-and-manufacturing-operations-in-u-k/ 2018-11-09T09:42:51+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Quotient-Sciences-Logo.jpg http://www.pharmajournalist.com/fda-approves-lorbrena-lorlatinib-for-previously-treated-alk-positive-metastatic-nsclc/ 2018-11-09T09:45:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/regulatory-issues-for-pf-syringes-injectable-drug-devices/ 2018-11-09T15:24:36+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Pre-Filled-Syringes-Europe_Pharma-Journalist.jpg http://www.pharmajournalist.com/boehringer-ingelheim-and-lilly-present-full-results-of-trajentas-carmelina-cardiovascular-outcome-trial/ 2018-11-13T09:35:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/parallel-trade-for-pharma-addressing-competition-law-and-fmd-challenges-registration-is-now-open/ 2018-11-13T12:32:00+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Parallel-Trade-Banner-Pharma-Journalist-SMi-Group.jpg http://www.pharmajournalist.com/pharmaceutical-microbiology-uk-speaker-interview-released-from-fresenius-kabi-ab/ 2018-11-14T07:11:02+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/300x250-Pharma-Micro-2019.jpg http://www.pharmajournalist.com/hear-vital-updates-on-delivery-mechanisms-of-rna-based-drugs-at-the-10th-annual-rna-therapeutics-conference/ 2018-11-14T07:19:48+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/RNA-Therapeutics-Banner-Pharma-Journalist.jpg http://www.pharmajournalist.com/astrazeneca-to-divest-us-synagis-rights-to-sobi/ 2018-11-16T07:40:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/crispr-therapeutics-and-maxcyte-expand-clinical-and-commercial-license-agreement-into-oncology/ 2018-11-16T07:43:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/mission-therapeutics-and-abbvie-sign-dubs-collaboration-in-alzheimers-and-parkinsons-disease/ 2018-11-16T07:45:27+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/dragonfly-therapeutics-announces-expansion-of-its-strategic-collaboration-with-celgene/ 2018-11-16T07:48:44+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Dragonfly-Therapeutics-logo.png http://www.pharmajournalist.com/grunenthal-acquires-averitas-pharma-and-establishes-commercial-footprint-in-the-us/ 2018-11-16T07:52:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/enable-injections-enters-into-strategic-partnerships-with-ucb-and-apellis-pharmaceuticals/ 2018-11-16T07:55:31+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/enable-injections-logo.png http://www.pharmajournalist.com/ferring-pharmaceuticals-enters-exclusive-agreement-with-invo-bioscience/ 2018-11-16T07:57:54+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Ferring-Pharmaceuticals-Singapore.jpg http://www.pharmajournalist.com/ziopharm-oncology-announces-immuno-oncology-clinical-supply-agreement-with-regeneron/ 2018-11-16T08:01:28+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Ziopharm-Oncology-Logo.jpg http://www.pharmajournalist.com/bridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics/ 2018-11-16T08:03:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/lonzas-global-subject-matter-expert-for-endotoxin-detection-appointed-chair-of-asmfc-horseshoe-crab-advisory-panel/ 2018-11-16T08:09:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/lonza.jpg http://www.pharmajournalist.com/sgs-expands-elemental-impurity-testing-services-at-its-laboratory-in-chennai-india/ 2018-11-16T08:11:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/sgs-logo.jpg http://www.pharmajournalist.com/catalent-to-open-second-clinical-supply-facility-in-china/ 2018-11-16T08:13:44+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Catalent-Logo.png http://www.pharmajournalist.com/metrics-contract-services-announces-serialization-capabilities-at-greenville-site/ 2018-11-16T08:17:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/abbvies-mavyret-shows-high-virologic-cure-rates-in-treatment-naive-hepatitis-c-patients-with-compensated-cirrhosis/ 2018-11-16T08:21:05+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/pain-therapeutics-appeals-fda-decision-on-remoxy/ 2018-11-16T08:23:35+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Pain-Therapeutics-Logo.jpg http://www.pharmajournalist.com/aimmune-therapeutics-announces-additional-equity-investment-by-nestle-health-science/ 2018-11-16T08:25:35+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Aimmune-Therapeutics-logo.png http://www.pharmajournalist.com/nexus-pharma-receives-fda-approval-for-arsenic-trioxide-injection-in-10mg-per-10ml-vial/ 2018-11-16T08:29:00+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Arsenic_Trioxide_Vial.jpg https://pharmajournalist.com/wp-content/uploads/2018/11/Arsenic_Trioxide_Vial.jpg http://www.pharmajournalist.com/fda-grants-breakthrough-therapy-designation-to-adcetris-for-frontline-peripheral-t-cell-lymphomas/ 2018-11-16T08:31:30+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Seattle-Genetics.jpg http://www.pharmajournalist.com/adynxx-and-twoxar-form-collaboration-to-discover-and-develop-treatments-for-endometriosis/ 2018-11-16T08:33:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/boehringer-and-epizyme-announce-worldwide-collaboration-to-develop-novel-epigenetic-oncology-therapies/ 2018-11-16T08:35:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/five-prime-therapeutics-initiates-patient-dosing-in-a-phase-1-clinical-trial-of-fpt155/ 2018-11-16T08:46:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/five-prime-therapeutics-inc-lo.png http://www.pharmajournalist.com/microbiotica-join-the-microbiome-movement-as-industry-partner/ 2018-11-16T15:56:52+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Microbiome-Movement-Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/edwards-life-sciences-to-open-the-next-annual-parallel-trade-and-patient-safety-session/ 2018-11-21T11:03:17+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Parallel-Trade-Banner-Pharma-Journalist-SMi-Group.jpg http://www.pharmajournalist.com/obi-pharma-granted-fda-orphan-drug-designation-for-obi-888-for-the-treatment-of-pancreatic-cancer/ 2018-11-23T08:33:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/esmo-launches-new-partnership-to-foster-asian-european-collaboration-on-rare-cancers/ 2018-11-23T08:37:48+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/ESMO-Logo.jpg http://www.pharmajournalist.com/cambrex-to-acquire-avista-pharma-solutions/ 2018-11-23T08:40:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/cambrex.jpeg http://www.pharmajournalist.com/fda-approves-gamifant-emapalumab-lzsg-the-first-and-only-treatment-indicated-for-primary-hlh/ 2018-11-23T08:43:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/sobi.jpg http://www.pharmajournalist.com/alvotech-and-fuji-pharma-enters-into-exclusive-agreement/ 2018-11-23T08:45:59+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/ALVOTECH-AND-FUJI-Agreement.jpg https://www.pharmajournalist.com/wp-content/uploads/2018/11/ALVOTECH-AND-FUJI-Agreement.jpg http://www.pharmajournalist.com/roivant-sciences-and-intron-bio-sign-licensing-deal-for-novel-anti-superbugs-biologic-sal200/ 2018-11-23T08:47:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/syntropy-to-unlock-the-value-of-scientific-data-in-fight-to-end-cancer/ 2018-11-23T08:49:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/wuxi-biologics-commenced-construction-of-1-6-million-sq-ft-biologics-innovation-center-in-shanghai/ 2018-11-23T08:56:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/wuxi-biologics-logo.png http://www.pharmajournalist.com/hitgen-and-biogen-enter-a-dna-encoded-library-based-drug-discovery-research-collaboration/ 2018-11-23T08:58:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Biogen-logo.jpg http://www.pharmajournalist.com/ligand-announces-omniab-partnership-with-imetabolic-biopharma-corporation/ 2018-11-23T08:59:56+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Ligand-Pharmaceuticals-logo.png http://www.pharmajournalist.com/leo-pharma-and-pellepharm-announce-760-million-collaboration-to-advance-innovative-therapies-for-rare-skin-diseases/ 2018-11-23T09:01:13+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/leo-pharma.jpg http://www.pharmajournalist.com/ascletis-and-roche-enter-exclusive-pegasys-partnership-in-china-for-viral-hepatitis/ 2018-11-23T09:05:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/innovus-pharma-acquires-worldwide-rights-to-four-products-from-boston-topicals/ 2018-11-23T09:07:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/innovus-pharma-office.jpg http://www.pharmajournalist.com/direct-biologics-has-acquired-paisley-laboratories/ 2018-11-23T09:09:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/ampersand-capital-partners-acquires-pacific-biomarkers-and-merges-company-with-neomed-labs/ 2018-11-23T09:13:19+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Ampersand-Logo.jpg http://www.pharmajournalist.com/marken-establishes-new-collaboration-with-rarechannels/ 2018-11-23T09:25:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/piramal-pharma-solutions-unveils-its-new-cgmp-kilo-lab-suite-for-api-at-ennore-chennai/ 2018-11-23T09:27:42+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Piramal-Pharma-Solutions-Logo.png http://www.pharmajournalist.com/immunocore-to-co-develop-imc-c103c-a-t-cell-redirecting-bi-specific-biologic-with-genentech/ 2018-11-23T09:29:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/immunocore.jpg http://www.pharmajournalist.com/casi-pharmaceuticals-to-build-gmp-manufacturing-site-in-wuxi-china/ 2018-11-23T09:31:11+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/casi-pharmaceuticals-logo.png http://www.pharmajournalist.com/gsk-submits-us-regulatory-filing-to-expand-the-use-of-nucala-in-children-with-severe-eosinophilic-asthma/ 2018-11-23T09:37:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gsk.jpg http://www.pharmajournalist.com/evotec-and-immuneering-to-collaborate-on-ai-driven-ligand-identification-for-rare-hereditary-metabolic-diseases/ 2018-11-23T09:41:17+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Immuneering-Logo.png http://www.pharmajournalist.com/smis-drug-discovery-chemistry-announces-key-industry-speakers-and-agenda-released/ 2018-11-23T11:16:37+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Drug-Discovery-Chemistry-Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/interview-released-with-novartis-ahead-of-pre-filled-syringes-injectable-drug-devices-europe-2019/ 2018-11-27T09:46:25+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Pre-Filled-Syringes-Europe_Pharma-Journalist.jpg http://www.pharmajournalist.com/world-health-organisations-senior-advisor-to-speak-at-21st-annual-superbugs-superdrugs-conference/ 2018-11-28T09:21:47+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Superbugs-Superdrugs-2018-Banner-Pharma-Journalist.jpg http://www.pharmajournalist.com/genentech-acquires-jecure-therapeutics/ 2018-11-30T08:21:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/european-commission-approves-mercks-delstrigo/ 2018-11-30T08:22:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/sandoz-receives-eighth-ec-approval-for-a-biosimilar-with-ziextenzo-pegfilgrastim/ 2018-11-30T08:24:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/sandoz.jpg http://www.pharmajournalist.com/fda-grants-fasenra-orphan-drug-designation-for-eosinophilic-granulomatosis-with-polyangiitis/ 2018-11-30T08:34:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/european-commission-approves-mundipharmas-pelmeg-to-treat-febrile-neutropenia/ 2018-11-30T08:36:53+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Mundipharma-Logo.png http://www.pharmajournalist.com/abcellera-collaborates-with-autolus-on-antibody-discovery-project/ 2018-11-30T08:39:47+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/AbCellera-Logo.jpg http://www.pharmajournalist.com/coeptis-pharma-enters-into-agreement-to-acquire-elto-pharma/ 2018-11-30T08:42:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/telix-and-nihon-medi-physics-to-collaborate-on-actinium-renal-cancer-therapeutics/ 2018-11-30T08:43:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/generex-biotechnology-expands-medical-device-portfolio-with-acquisition-of-olaregen-therapeutix/ 2018-11-30T08:46:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/aiping-pharmaceutical-strikes-ibuprofen-deal-with-xinhua-pharmaceutical/ 2018-11-30T08:48:43+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/AiPing-Pharmaceuticals-Logo.png http://www.pharmajournalist.com/machavert-pharmaceuticals-unveils-a-new-bioactive-lipid-drug-candidate-for-cancer-treatment/ 2018-11-30T08:50:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.png http://www.pharmajournalist.com/vir-biotechnology-and-alnylam-pharmaceuticals-initiate-phase-1-2-study-of-vir-2218/ 2018-11-30T08:51:57+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/alnylam-pharmaceuticals_logo.jpg http://www.pharmajournalist.com/fusion-antibodies-and-analytics-engines-to-incorporate-artificial-intelligence-into-its-world-class-antibody-humanization-service/ 2018-11-30T08:55:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Fusion_Antibodies.jpg http://www.pharmajournalist.com/fda-approves-first-treatment-for-lambert-eaton-myasthenic-syndrome-a-rare-autoimmune-disorder/ 2018-11-30T08:57:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/tracon-and-i-mab-announce-strategic-partnerships-for-multiple-immuno-oncology-programs/ 2018-11-30T08:59:44+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Tracon-Pharma-Logo.png http://www.pharmajournalist.com/ajinomoto-bio-pharma-services-introduces-ajicap-bioconjugation-technology-for-adc-manufacturing/ 2018-11-30T09:13:21+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Ajinomoto-Bio-Pharma-Services_Logo.png http://www.pharmajournalist.com/evelo-enters-into-clinical-trial-collaboration-agreement-with-merck/ 2018-11-30T09:16:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/aileron-enters-clinical-trial-collaboration-with-pfizer/ 2018-11-30T09:18:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/catalent-expands-clinical-packaging-capabilities-in-shanghai-china/ 2018-11-30T09:20:10+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Catalent-Logo.png http://www.pharmajournalist.com/telix-pharmaceuticals-acquires-advanced-nuclear-medicine-ingredients-anmi-sa/ 2018-11-30T09:22:32+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Telix-Pharmaceuticals-Logo.jpg http://www.pharmajournalist.com/edge-therapeutics-enters-into-merger-agreement-with-pds-biotechnology-to-form-clinical-stage-cancer-immunotherapy-company/ 2018-11-30T09:25:10+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Edge-Therapeutics-Logo.jpg http://www.pharmajournalist.com/cbt-and-zhejiang-bossan-enter-into-a-collaboration-and-license-agreement-to-develop-combination-cancer-treatments/ 2018-11-30T09:28:01+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/CBT-Pharma-Logo.jpg http://www.pharmajournalist.com/vedanta-biosciences-announces-initiation-of-phase-1-clinical-study-with-janssen-of-microbiome-derived-product-candidate-for-inflammatory-bowel-disease/ 2018-11-30T09:32:39+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Vedanta_Biosciences_Logo.jpg http://www.pharmajournalist.com/octapharma-receives-swissmedic-approval-for-fibryga-to-treat-congenital-and-acquired-fibrinogen-deficiencies/ 2018-11-30T09:36:58+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Octapharma-Logo.png http://www.pharmajournalist.com/invitation-from-james-drinkwater-chairing-the-2nd-annual-pharmaceutical-microbiology-east-coast-conference/ 2018-12-03T07:26:10+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/Pharma-Micro-East-Coast-2019-Pharma-Journalist.jpg http://www.pharmajournalist.com/registration-opens-for-the-11th-adaptive-designs-in-clinical-trials/ 2018-12-03T10:45:46+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Adaptive-Design-in-Clincal-Trials-Phama-Journalist.jpg http://www.pharmajournalist.com/invitation-from-ekkehard-leberer-senior-director-at-sanofi-aventis-deutschland-gmbh-chair-of-next-years-rna-therapeutics-conference-in-london/ 2018-12-06T09:52:35+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/RNA-Therapeutics-Banner-Pharma-Journalist.jpg http://www.pharmajournalist.com/the-strategies-to-reach-out-and-engage-with-your-customers/ 2018-12-06T09:58:40+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Social-Media-in-Pharmaceutical-Industry-Banner-Pharma-Journalist.jpg http://www.pharmajournalist.com/fda-grants-priority-review-to-roches-tecentriq-in-combination-with-chemotherapy-for-the-initial-treatment-of-extensive-stage-small-cell-lung-cancer/ 2018-12-07T09:24:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/mylan-expands-gastroenterology-portfolio-with-launch-of-generic-for-prevacid-solutab-delayed-release-orally-disintegrating-tablets/ 2018-12-07T09:26:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/mylan-1.jpg http://www.pharmajournalist.com/ucb-announces-approval-of-vimpat-in-china/ 2018-12-07T09:30:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/ucb-pharma.jpg http://www.pharmajournalist.com/phase-3-trial-of-rova-t-as-second-line-therapy-for-advanced-small-cell-lung-cancer-tahoe-study-halted/ 2018-12-07T09:32:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/abbvie.jpg http://www.pharmajournalist.com/novartis-announces-fda-filing-acceptance-and-priority-review-of-avxs-101/ 2018-12-07T09:42:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/parexel-collaborates-with-eli-lilly-and-company-to-develop-chinas-clinical-research-workforce/ 2018-12-07T09:45:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/parexel-clinical.jpg http://www.pharmajournalist.com/icagen-enters-into-collaboration-to-develop-and-commercialize-therapy-for-neurological-diseases/ 2018-12-07T09:48:17+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/icagen_logo.jpg http://www.pharmajournalist.com/revance-announces-china-market-license-agreement-with-fosun-pharma-for-rt002/ 2018-12-07T09:50:17+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/revance-logo.jpg http://www.pharmajournalist.com/pluristem-therapeutics-enters-into-cell-thawing-device-license-agreement-with-chart-industries/ 2018-12-07T09:52:24+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/Pluristem-Logo.png http://www.pharmajournalist.com/scientist-com-partners-with-allele-biotech-to-discover-and-develop-therapeutic-nanoantibodies/ 2018-12-07T09:54:52+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/Scientist.com-Logo.jpg http://www.pharmajournalist.com/sartorius-and-immunochina-partner-to-advance-immunotherapy-development/ 2018-12-07T09:57:28+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/Sartorius-Stedim-Biotech-Logo.png http://www.pharmajournalist.com/autolus-therapeutics-announces-update-on-its-novel-car-t-cell-program-for-peripheral-t-cell-lymphoma-ptcl/ 2018-12-07T10:01:03+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/Autolus_logo.jpg http://www.pharmajournalist.com/merck-kgaa-darmstadt-germany-in-agreement-with-cyclica-for-ai-augmented-screening-platform-to-expand-research-capabilities/ 2018-12-07T10:06:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/iqvias-oce-technology-platform-selected-by-napo-pharmaceuticals-to-increase-commercial-efficiency/ 2018-12-07T10:09:24+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/IQVIA-Logo.png http://www.pharmajournalist.com/chinese-drugmaker-changzhou-qianhong-bio-pharma-expands-pharma-production-facility/ 2018-12-07T10:12:41+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/Changzhou-Qianhong-Bio-pharma.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/12/Changzhou-Qianhong-Bio-pharma.jpg http://www.pharmajournalist.com/ondosis-and-recipharm-partner-to-advance-a-novel-treatment-regimen-for-adhd/ 2018-12-07T10:15:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/recipharm.jpg http://www.pharmajournalist.com/evotec-and-leo-pharma-form-drug-discovery-alliance-targeting-dermatological-conditions/ 2018-12-07T10:17:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/evotec.png http://www.pharmajournalist.com/novartis-advances-ligelizumab-qge031-in-urticaria-to-phase-iii-on-basis-of-strong-phase-ii-head-to-head-data/ 2018-12-07T10:33:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/momenta-pharmaceuticals-provides-update-on-us-regulatory-strategy-for-m923-proposed-biosimilar-to-humira/ 2018-12-07T10:36:02+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/Momenta-Logo.png http://www.pharmajournalist.com/ppd-expands-gmp-lab-testing-capabilities-for-biologics/ 2018-12-07T10:40:06+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/PPD%C2%AE-Laboratories%E2%80%99-Athlone-GMP-lab.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/12/PPD%C2%AE-Laboratories%E2%80%99-Athlone-GMP-lab.jpg http://www.pharmajournalist.com/%ef%bb%bfengage-withregulators-and-discuss-the-implementation-of-risk-based-approaches-to-assessoptimise-and-manage-the-quality-of-clinical-vendors-and-sites/ 2018-12-12T12:39:15+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/Clinical-Quality-Banner-Pharma-Journalist_ExL-Events.png http://www.pharmajournalist.com/novartis-receives-european-commission-approval-for-self-administration-of-xolair-across-all-indications/ 2018-12-14T08:17:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/gardp-eisai-and-takeda-announce-partnership-in-the-search-for-new-antibiotics/ 2018-12-14T08:21:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/vect-horus-announces-agreement-with-johnson-johnson-innovation/ 2018-12-14T08:25:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/amgen-and-magellan-rx-management-collaborate-to-improve-patient-care-for-chronic-difficult-to-treat-conditions/ 2018-12-14T08:28:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/bristol-myers-squibb-and-vedanta-announce-a-new-clinical-collaboration/ 2018-12-14T08:32:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/bristol-myers-squibb.jpg http://www.pharmajournalist.com/astrazeneca-and-cancer-research-uk-launch-functional-genomics-centre-to-accelerate-the-discovery-of-new-medicines/ 2018-12-14T08:35:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/gilead-sciences-names-daniel-oday-chairman-and-chief-executive-officer/ 2018-12-14T08:37:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/amag-pharmaceuticals-enters-into-definitive-merger-agreement-to-acquire-perosphere-pharmaceuticals/ 2018-12-14T08:43:03+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/Amag-Pharmaceuticals-Logo.jpg http://www.pharmajournalist.com/almirall-and-x-chem-announce-dermatology-focused-drug-discovery-collaboration/ 2018-12-14T08:46:50+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/Almirall.jpg http://www.pharmajournalist.com/lilly-and-ac-immune-announce-license-and-collaboration-agreement/ 2018-12-14T08:49:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/oxford-biotherapeutics-expands-strategic-collaboration-with-wuxi-biologics/ 2018-12-14T08:53:39+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/Oxford-Biotherapeutics-Logo.jpg http://www.pharmajournalist.com/genecentric-therapeutics-enters-bladder-cancer-research-collaboration-with-university-of-north-carolina/ 2018-12-14T08:56:45+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/Genecentric-Logo.jpg http://www.pharmajournalist.com/hitgen-and-mitsubishi-tanabe-pharma-enter-dna-encoded-library-based-innovative-drug-discovery-research-collaboration/ 2018-12-14T08:58:47+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/new-therapeutic-area-leaders-extend-ppds-drug-development-capabilities/ 2018-12-14T09:01:14+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/PPD-office_wikipedia.jpg http://www.pharmajournalist.com/dragonfly-therapeutics-announces-celgene-in-license-of-first-two-trinket-immunotherapy-drug-candidates/ 2018-12-14T09:03:39+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Dragonfly-Therapeutics-logo.png http://www.pharmajournalist.com/novo-nordisk-purchases-berkeley-lights-beacon-optofluidic-platform-for-cell-line-development-and-antibody-discovery/ 2018-12-14T09:06:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/novo-nordisk-logo.jpg http://www.pharmajournalist.com/cambrex-expands-analytical-capabilities-at-its-high-point-nc-site/ 2018-12-14T09:08:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/cambrex.jpeg http://www.pharmajournalist.com/wuxi-apptec-expands-site-in-california-for-pharmaceutical-rd-services/ 2018-12-14T09:10:46+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/wuxi-apptec-logo.png http://www.pharmajournalist.com/inveniai-enters-strategic-artificial-intelligence-collaboration-with-kyowa-hakko-kirin/ 2018-12-14T09:13:36+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/InveniAI-Logo.jpg http://www.pharmajournalist.com/avacta-and-lg-chem-life-sciences-agree-multi-target-affimer-therapeutics-development-alliance/ 2018-12-14T09:18:51+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/Avacta-Logo.jpg http://www.pharmajournalist.com/sgs-to-expand-bioanalytical-testing-capabilities-in-france-at-its-poitiers-laboratory/ 2018-12-14T09:20:43+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/sgs-logo.jpg http://www.pharmajournalist.com/schrodinger-and-tb-alliance-announce-collaboration-to-accelerate-tuberculosis-drug-discovery/ 2018-12-14T09:23:52+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/Schrodinger-Logo.jpg http://www.pharmajournalist.com/versant-ventures-launches-black-diamond-therapeutics/ 2018-12-14T09:27:13+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/Black-Diamond-Therapeutics-Logo.png http://www.pharmajournalist.com/alnylam-announces-settlement-of-litigation-with-silence-therapeutics/ 2018-12-14T09:29:16+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/alnylam-pharmaceuticals_logo.jpg http://www.pharmajournalist.com/promising-results-from-mina-therapeutics-on-treating-liver-cancer-as-cso-is-set-to-speak-at-rna-therapeutics-2019/ 2018-12-17T07:24:57+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/RNA-Therapeutics-Banner-Pharma-Journalist.jpg http://www.pharmajournalist.com/pfizers-vice-president-and-head-of-early-clinical-development-presents-at-the-11th-adaptive-designs-in-clinical-trials/ 2018-12-17T11:31:58+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Adaptive-Design-in-Clincal-Trials-Phama-Journalist.jpg http://www.pharmajournalist.com/exclusive-speaker-interviews-released-with-gsk-and-f-hoffman-la-roche-speakers-at-smis-drug-discovery-chemistry-conference/ 2018-12-19T14:04:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Drug-Discovery-Chemistry-Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/lynparza-meets-primary-endpoint-in-phase-iii-solo-3-trial/ 2018-12-21T04:53:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/astrazeneca-and-fibrogen-receive-approval-to-market-roxadustat-in-china/ 2018-12-21T04:57:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/amgen-and-molecular-partners-announce-strategic-collaboration-in-immuno-oncology/ 2018-12-21T05:03:28+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/pfizer-and-gsk-announce-joint-venture-to-create-a-premier-global-consumer-healthcare-company/ 2018-12-21T05:08:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/astellas-pfizer-announce-positive-top-line-results-from-phase-3-arches-trial-of-xtandi-enzalutamide-in-men-with-mhspc/ 2018-12-21T05:12:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/innovent-and-incyte-announce-strategic-collaboration-and-licensing-agreement-for-three-clinical-stage-product-candidates-in-china/ 2018-12-21T05:14:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/incyte-logo.jpg http://www.pharmajournalist.com/novartis-announces-new-ceo-of-oncology-business-unit/ 2018-12-21T05:20:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/sandoz-enters-into-commercialization-and-supply-agreement-for-insulin-biosimilars-anticipating-growing-demand-as-diabetes-burden-rises/ 2018-12-21T05:23:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/sandoz.jpg http://www.pharmajournalist.com/novartis-announces-offer-to-acquire-cellforcure-to-expand-manufacturing-capacity-for-innovative-cell-and-gene-therapies/ 2018-12-21T05:26:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/bioarctic-outlicenses-its-alpha-synuclein-antibody-portfolio-for-parkinsons-disease-to-abbvie-after-receiving-clearance/ 2018-12-21T05:29:07+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/nicox-and-ocumension-sign-exclusive-license-agreement-to-develop-and-commercialize-ncx-470-in-the-chinese-market/ 2018-12-21T05:32:59+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/Nicox-Logo.jpg http://www.pharmajournalist.com/gilead-and-agenus-enter-into-collaboration-to-develop-immuno-oncology-therapies/ 2018-12-21T05:36:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/ascentage-pharma-announces-strategic-collaboration-with-genor-biopharma/ 2018-12-21T05:40:34+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/Ascentage-Pharma.png http://www.pharmajournalist.com/lilly-and-aduro-biotech-announce-research-collaboration-and-license-agreement-to-develop-novel-immunotherapies/ 2018-12-21T05:43:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/delsitech-and-innovare-sign-licensing-agreement-for-the-development-of-a-long-acting-hiv-therapy/ 2018-12-21T05:46:20+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/delsitech-logo.png http://www.pharmajournalist.com/proteostasis-therapeutics-announces-global-license-agreement-with-genentech/ 2018-12-21T06:02:27+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/Proteostasis-Therapeutics.png http://www.pharmajournalist.com/astellas-acquires-potenza-therapeutics/ 2018-12-21T06:06:12+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astellas.jpg http://www.pharmajournalist.com/merck-kgaa-darmstadt-germany-assigns-chimeric-antigen-receptor-t-cell-car-t-rights-to-intrexon/ 2018-12-21T06:09:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/teva-reports-positive-results-for-fremanezumab-in-phase-iiib-migraine-trial/ 2018-12-21T06:12:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/TEVA-Pharma.jpg http://www.pharmajournalist.com/mustang-bio-receives-orphan-drug-designation-for-mb-102-cd123-car-t/ 2018-12-21T06:16:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/mustang-bio-logo.jpg http://www.pharmajournalist.com/bridge-biotherapeutics-signs-us40m-license-agreement-with-daewoong-for-co-development-of-uc-drug-candidate/ 2018-12-21T06:19:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/wuxi-biologics-and-ac-immune-to-establish-an-exclusive-strategic-partnership/ 2018-12-21T06:23:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/wuxi-biologics-logo.png http://www.pharmajournalist.com/recipharm-to-potentially-end-operations-in-ashton-under-lyne-facility/ 2018-12-21T06:27:19+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/recipharm.jpg http://www.pharmajournalist.com/teneobio-and-selexis-enter-second-services-agreement/ 2018-12-21T06:31:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Selexis-SA-logo.jpg http://www.pharmajournalist.com/exclusive-interview-released-from-sanofi-pasteur-speaker-at-pharma-micro-uk-smi-conference/ 2019-01-03T09:50:41+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/300x250-Pharma-Micro-2019.jpg http://www.pharmajournalist.com/microbiologists-receive-a-personal-invite-from-james-drinkwater/ 2019-01-03T12:09:09+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/Pharma-Micro-East-Coast-2019-Pharma-Journalist.jpg http://www.pharmajournalist.com/less-than-four-weeks-to-go-until-europes-only-parallel-trade-conference-taking-place-in-london/ 2019-01-07T11:55:14+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Parallel-Trade-Banner-Pharma-Journalist-SMi-Group.jpg http://www.pharmajournalist.com/canbridge-pharmaceuticals-and-wuxi-biologics-expand-rare-disease-therapeutics-partnership/ 2019-01-11T07:35:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/wuxi-biologics-logo.png http://www.pharmajournalist.com/cytoreason-signs-collaboration-agreement-with-pfizer/ 2019-01-11T07:37:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/three-dimensional-cell-cultures-as-predictive-tools-in-early-drug-discovery/ 2019-01-11T07:42:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/3D-Cell-Culture-Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/janssen-submits-application-to-european-medicines-agency-seeking-approval-of-stelara/ 2019-01-11T07:44:51+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/Janssen.jpg http://www.pharmajournalist.com/regeneron-and-sanofi-restructure-immuno-oncology-collaboration-for-discovery-and-development-programs/ 2019-01-11T07:54:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/regeneron.jpg http://www.pharmajournalist.com/sirion-and-denali-join-forces-to-develop-gene-therapies-for-diseases-of-the-central-nervous-system/ 2019-01-11T07:58:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical.jpg http://www.pharmajournalist.com/absci-establishes-new-collaboration-with-sanofi/ 2019-01-11T08:00:46+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/generex-biotechnology-completes-acquisition-of-olaregen-therapeutix/ 2019-01-11T08:02:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/ascentage-pharma-announces-new-license-with-unity-biotechnology/ 2019-01-11T08:06:30+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/Ascentage-Pharma.png http://www.pharmajournalist.com/ampliphi-biosciences-and-c3j-therapeutics-agree-to-merge/ 2019-01-11T08:09:04+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/AmpliPhi-Logo.jpg http://www.pharmajournalist.com/ge-healthcare-vanderbilt-university-medical-center-partner-for-safer-more-precise-immunotherapy-cancer-treatment/ 2019-01-11T08:14:35+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/GE-Healthcare.jpg http://www.pharmajournalist.com/aphena-ready-for-opioid-crisis-response-act/ 2019-01-11T08:17:19+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/The-Pharmaworks-TF2.jpg http://www.pharmajournalist.com/wp-content/uploads/2019/01/The-Pharmaworks-TF2.jpg http://www.pharmajournalist.com/pii-to-manufacture-fda-approved-bretylium-tosylate-injection-drug-product/ 2019-01-11T08:20:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/neurobo-to-initiate-phase-iii-clinical-trial-of-nb-01-in-adult-patients-with-diabetic-neuropathic-pain/ 2019-01-11T08:23:10+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/NeuroBo-Logo.jpg http://www.pharmajournalist.com/almac-group-flows-into-continuous-technology/ 2019-01-11T08:26:16+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/Almac-Group_Flow-Chemistry.jpg http://www.pharmajournalist.com/wp-content/uploads/2019/01/Almac-Group_Flow-Chemistry.jpg http://www.pharmajournalist.com/takeda-completes-acquisition-of-shire/ 2019-01-11T08:32:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/novartis-investigational-therapy-crizanlizumab-seg101-receives-fda-breakthrough-therapy-designation/ 2019-01-11T08:34:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/biolive-china-2019-to-be-newly-upgraded-to-lead-the-development-of-the-bio-pharma-technology-in-asia/ 2019-01-11T08:34:49+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/CPhIP-MEC-Pharma-Journalist.jpg https://pharmajournalist.com/wp-content/uploads/2019/01/1.jpg https://pharmajournalist.com/wp-content/uploads/2019/01/2.jpg https://pharmajournalist.com/wp-content/uploads/2019/01/3.jpg https://pharmajournalist.com/wp-content/uploads/2019/01/4.jpg http://www.pharmajournalist.com/samdi-tech-promotes-michael-d-scholle-to-chief-operating-officer/ 2019-01-11T08:41:07+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/Michael-D.-Scholle.png https://pharmajournalist.com/wp-content/uploads/2019/01/Michael-D.-Scholle.png http://www.pharmajournalist.com/clinigen-extends-exclusive-european-clinical-trial-sourcing-and-supply-agreement-with-accord-healthcare/ 2019-01-11T08:44:11+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/Clinigen-Logo.png http://www.pharmajournalist.com/chinese-api-market-growing-strongly-cphi-china-assisting-enterprises-with-the-transformation-innovation-and-comprehensive-upgrading/ 2019-01-11T08:46:45+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/CPhIP-MEC-Pharma-Journalist-Banner.jpg https://pharmajournalist.com/wp-content/uploads/2019/01/5.png https://pharmajournalist.com/wp-content/uploads/2019/01/6.png https://pharmajournalist.com/wp-content/uploads/2019/01/7.png http://www.pharmajournalist.com/velabs-therapeutics-to-cooperate-with-biomed-x-in-the-field-of-immunology/ 2019-01-11T08:47:20+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/Logo_Velabs.png http://www.pharmajournalist.com/selexis-expands-strategic-immuno-oncology-alliance-with-agenus/ 2019-01-11T08:51:26+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Selexis-SA-logo.jpg http://www.pharmajournalist.com/key-pharmaceuticals-ltd-to-lead-a-workshop-on-parallel-trade-brexit-during-the-13th-annual-parallel-trade-conference/ 2019-01-14T09:36:39+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Parallel-Trade-Banner-Pharma-Journalist-SMi-Group.jpg http://www.pharmajournalist.com/pharmaceutical-microbiology-uk-confex-takes-place-in-less-than-a-week/ 2019-01-16T15:25:34+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/300x250-Pharma-Micro-2019.jpg http://www.pharmajournalist.com/tom-parke-to-lead-a-workshop-on-the-new-fda-draft-guidance-on-adaptive-designs-during-the-11th-annual-conference/ 2019-01-16T15:29:50+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Adaptive-Design-in-Clincal-Trials-Phama-Journalist.jpg http://www.pharmajournalist.com/human-factor-considerations-in-pre-filled-syringes-development-focus-of-smis-pre-filled-syringes-east-coast-usa-annual-conference/ 2019-01-17T09:47:27+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/Pre-Filled-Syringes-East-Coast-Banner-Pharma-Journalist.jpg http://www.pharmajournalist.com/wp-content/uploads/2018/12/Pre-Filled-Syringes-East-Coast-Banner-Pharma-Journalist.jpg http://www.pharmajournalist.com/invitation-from-roderick-e-hubbard-at-vernalis-research-chairing-smis-drug-discovery-conference/ 2019-01-17T16:26:29+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Drug-Discovery-Chemistry-Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/fda-accepts-regulatory-submissions-for-review-of-tafamidis-to-treat-transthyretin-amyloid-cardiomyopathy/ 2019-01-18T08:28:52+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/puma-and-knight-enter-into-exclusive-license-agreement-to-commercialize-nerlynx-neratinib-in-canada/ 2019-01-18T08:30:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/puma-biotechnology.jpg http://www.pharmajournalist.com/amag-pharmaceuticals-completes-acquisition-of-perosphere-pharmaceuticals/ 2019-01-18T08:33:45+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/Amag-Pharmaceuticals-Logo.jpg http://www.pharmajournalist.com/ablexis-announces-expansion-of-non-exclusive-perpetual-license-agreement-with-eli-lilly-and-company/ 2019-01-18T08:38:03+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/Ablexis_Logo.jpg http://www.pharmajournalist.com/phoenix-molecular-designs-announces-collaboration-to-develop-diagnostic-for-triple-negative-breast-cancer/ 2019-01-18T08:42:07+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/Phoenix-Molecular-Designs.jpg http://www.pharmajournalist.com/biomed-x-and-boehringer-to-investigate-early-intervention-in-psychiatric-diseases/ 2019-01-18T08:46:45+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/BioMed-X-Logo.jpg http://www.pharmajournalist.com/cobra-biologics-appoints-dr-darrell-sleep-as-director-of-innovation/ 2019-01-18T08:50:37+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/Darrell-Sleep.jpg https://pharmajournalist.com/wp-content/uploads/2019/01/Darrell-Sleep.jpg http://www.pharmajournalist.com/luye-pharma-reaches-strategic-partnership-with-astrazeneca/ 2019-01-18T09:11:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/schott-to-invest-300-million-euros-in-pharmaceutical-packaging-business/ 2019-01-18T09:15:09+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/schott-muellheim.jpg http://www.pharmajournalist.com/wp-content/uploads/2019/01/schott-muellheim.jpg http://www.pharmajournalist.com/sln124-granted-orphan-drug-designation-by-ema-for-the-treatment-of-%ce%b2-thalassemia/ 2019-01-18T09:19:06+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/Silence-Therapeutics-Logo.png http://www.pharmajournalist.com/exelixis-announces-fda-approval-of-cabometyx-cabozantinib-tablets-for-previously-treated-hepatocellular-carcinoma/ 2019-01-18T09:22:50+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/Exelixis-Logo.png http://www.pharmajournalist.com/zymeworks-reports-second-investigational-new-drug-ind-submission-milestone-achieved-in-lilly-collaboration/ 2019-01-18T09:26:36+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/ZymeWorks-Logo.png http://www.pharmajournalist.com/aerpio-announces-completion-of-patient-dosing-in-time-2b-study-of-akb-9778-in-diabetic-retinopathy/ 2019-01-18T09:30:52+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/aerpio-Pharmaceuticals-Logo.png http://www.pharmajournalist.com/nexus-pharmaceuticals-announces-fda-approval-of-busulfan-injection/ 2019-01-18T09:33:50+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/Nexus-Pharma-Logo.jpg http://www.pharmajournalist.com/linzess-linaclotide-approved-in-china-for-the-treatment-of-irritable-bowel-syndrome-with-constipation/ 2019-01-18T09:36:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/lipocines-nash-therapy-candidate-achieves-meaningful-liver-fat-reduction-based-on-interim-results/ 2019-01-18T09:41:54+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/LIPOCINE.jpg http://www.pharmajournalist.com/aivita-biomedical-receives-ind-clearance-for-phase-1b-melanoma-trial/ 2019-01-18T09:44:55+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/Aivita-Biomedical-Logo.png http://www.pharmajournalist.com/fda-approves-first-generic-version-of-sabril-to-help-treat-seizures-in-adults-and-pediatric-patients-with-epilepsy/ 2019-01-18T09:46:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/abbott-to-acquire-cephea-valve-technologies/ 2019-01-18T09:48:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Abbott1.png http://www.pharmajournalist.com/putting-worker-safety-and-product-quality-at-the-forefront-of-the-hpapi-industry-highly-potent-active-pharmaceutical-ingredients-2019/ 2019-01-18T13:19:26+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/HAPAPI-Banner-SMi-Pharma-Journalist.jpg http://www.pharmajournalist.com/wp-content/uploads/2019/01/HAPAPI-Banner-SMi-Pharma-Journalist-Leaderboard.jpg http://www.pharmajournalist.com/genentech-develop-antibiotic-effective-against-gram-negative-bacteria-with-potential-to-lead-to-new-class-of-antibiotics/ 2019-01-21T08:18:30+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Superbugs-Superdrugs-2018-Banner-Pharma-Journalist.jpg http://www.pharmajournalist.com/2nd-annual-pharma-regulatory-summit-2019/ 2019-01-21T08:35:54+00:00 http://www.pharmajournalist.com/registration-opens-for-smis-2nd-injectable-drug-delivery-2019/ 2019-01-23T09:14:44+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/Injectable-Drug-Delivery-2019_Pharma-Journalist.jpg http://www.pharmajournalist.com/proqr-to-present-at-smis-rna-therapeutics-2019-after-their-latest-development-of-a-rna-based-oligonucleotide-to-treat-vision-loss/ 2019-01-23T11:53:56+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/RNA-Therapeutics-Banner-Pharma-Journalist.jpg http://www.pharmajournalist.com/only-four-weeks-till-smis-3d-cell-culture-conference-2019/ 2019-01-24T07:18:17+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/3D-Cell-Culture-Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/registration-opens-for-smis-leading-pain-therapeutics-conference/ 2019-01-25T11:35:00+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/PainTherapeutics_Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/fda-advisory-committee-votes-on-zynquista-sotagliflozin-as-treatment-for-adults-with-type-1-diabetes/ 2019-01-25T11:38:52+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/peptidream-announces-new-peptide-drug-conjugate-pdc-discovery-deal-with-shionogi/ 2019-01-25T11:41:24+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/peptiDream-logo.jpg http://www.pharmajournalist.com/gsk-completes-acquisition-of-tesaro/ 2019-01-25T11:44:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/alnylam-and-medison-pharma-partner-to-commercialize-rnai-therapeutics-in-israel/ 2019-01-25T11:48:39+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/alnylam-pharmaceuticals_logo.jpg http://www.pharmajournalist.com/fda-approves-ontruzant-trastuzumab-dttb-samsung-bioepis-first-oncology-medicine-in-the-united-states/ 2019-01-25T11:52:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/biontech-to-acquire-antibody-generation-unit-of-mab-discovery/ 2019-01-25T11:55:03+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/BioNTech-AG.jpg http://www.pharmajournalist.com/philogen-announces-drug-discovery-collaboration-with-johnson-johnson-innovation/ 2019-01-25T11:57:37+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/Philogen-Logo.jpg http://www.pharmajournalist.com/gamida-cell-and-be-the-match-biotherapies-announce-strategic-collaboration/ 2019-01-25T12:03:34+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/Gamida-Cell-Logo.jpg http://www.pharmajournalist.com/ferring-rebiotix-and-karolinska-institutet-extend-collaboration-to-research-next-generation-of-microbiome-treatments/ 2019-01-25T12:06:04+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Ferring-Pharmaceuticals-Singapore.jpg http://www.pharmajournalist.com/b-mogen-and-cytosen-therapeutics-partner-on-research-collaboration/ 2019-01-25T12:12:08+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/B-MOGEN-Biotechnologies_logo.png http://www.pharmajournalist.com/basilea-announces-collaboration-to-study-derazantinib-and-atezolizumab-tecentriq-in-urothelial-cancer/ 2019-01-25T12:15:30+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/Basilea.jpg http://www.pharmajournalist.com/lonza-to-commence-commercial-supply-of-portolas-second-generation-andexxa/ 2019-01-25T12:17:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/lonza.jpg http://www.pharmajournalist.com/camp4-therapeutics-announces-rare-disease-research-collaboration-with-alnylam/ 2019-01-25T12:21:43+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/CAMP4-Therapeutics.png http://www.pharmajournalist.com/rigel-enters-collaboration-and-license-agreement-with-grifols-to-commercialize-fostamatinib-in-europe/ 2019-01-25T12:24:18+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Rigel-Pharma-Logo.png http://www.pharmajournalist.com/ironwood-pharmaceuticals-initiates-phase-1-trial-of-iw-6463/ 2019-01-25T12:41:06+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Ironwood-Pharmaceuticals-Logo.png http://www.pharmajournalist.com/vertex-announces-european-commission-approval-for-orkambi-lumacaftor-ivacaftor/ 2019-01-25T12:43:31+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/vertex-pharma-logo.png http://www.pharmajournalist.com/concert-pharma-initiates-phase-1-single-ascending-dose-trial-of-ctp-692-as-an-adjunctive-treatment-for-schizophrenia/ 2019-01-25T12:47:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/concert-pharmaceuticals.jpg http://www.pharmajournalist.com/ferring-appoints-sophie-opdyke-to-lead-its-new-u-s-oncology-division/ 2019-01-25T12:50:29+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/Sophie-Opdyke.jpg https://pharmajournalist.com/wp-content/uploads/2019/01/Sophie-Opdyke.jpg http://www.pharmajournalist.com/incyte-announces-first-patient-treated-in-phase-3-clinical-trial-of-itacitinib-for-chronic-graft-versus-host-disease/ 2019-01-25T12:52:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/incyte-logo.jpg http://www.pharmajournalist.com/alvotech-completes-u-s-300m-financing-deal/ 2019-01-25T12:55:29+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/Alvotech.jpg http://www.pharmajournalist.com/an-interview-with-heiko-goette-biostatistician-merck-ahead-of-adaptive-designs-in-clinical-trials-just-released/ 2019-01-28T11:44:13+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Adaptive-Design-in-Clincal-Trials-Phama-Journalist.jpg http://www.pharmajournalist.com/join-experts-within-pharmaceuticals-and-life-sciences-in-just-one-week-at-europes-only-parallel-trade-conference-2019-in-london/ 2019-01-29T11:22:39+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Parallel-Trade-Banner-Pharma-Journalist-SMi-Group.jpg http://www.pharmajournalist.com/horizon-discovery-and-rutgers-university-form-exclusive-partnership-to-develop-next-generation-novel-gene-editing-technology/ 2019-02-01T10:02:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/horizon_logo.png http://www.pharmajournalist.com/invenra-and-warf-initiate-a-collaboration-to-discover-and-develop-novel-therapeutics-to-fight-neuroblastoma-in-children/ 2019-02-01T10:06:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/alexion-and-caelum-announce-collaboration-to-develop-targeted-therapy-for-light-chain-al-amyloidosis/ 2019-02-01T10:09:57+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Alexion-Pharma-Logo.png http://www.pharmajournalist.com/repare-therapeutics-announces-a-strategic-partnership-agreement-with-ono-pharmaceutical/ 2019-02-01T10:12:39+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Repare-Therapeutics-Logo.jpg http://www.pharmajournalist.com/cannassure-therapeutics-announces-strategic-partnership-with-cannika-holdings/ 2019-02-01T10:14:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/wcg-partners-with-prudentia-group-to-enhance-drug-safety-in-clinical-development/ 2019-02-01T10:17:35+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/WCG-Logo.jpg http://www.pharmajournalist.com/facit-and-triphase-accelerator-announce-new-partnership-with-celgene-for-first-in-class-wdr5-leukemia-therapy/ 2019-02-01T10:20:56+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Facit-Logo.jpg http://www.pharmajournalist.com/olon-s-p-a-acquires-capua-bioservices-s-p-a/ 2019-02-01T10:23:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/olonspa-logo.jpg http://www.pharmajournalist.com/eureka-therapeutics-announces-fda-clearance-of-ind-application-for-phase-1-2-trial-of-et140202-artemis-t-cell-therapy/ 2019-02-01T10:28:54+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Eureka-Therapeutics-Logo.png http://www.pharmajournalist.com/pfizer-and-lilly-announce-top-line-results-from-second-phase-3-study-of-tanezumab-in-osteoarthritis-pain/ 2019-02-01T10:40:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/lyndra-therapeutics-raises-55-million-in-series-b-financing/ 2019-02-01T10:44:09+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Lyndra-Therapeutics-Logo.png http://www.pharmajournalist.com/fortress-biotech-announces-cael-101-strategic-partnership-with-alexion-pharmaceuticals/ 2019-02-01T10:48:34+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Fortress-Biotech-logo.jpg http://www.pharmajournalist.com/janssen-and-meiragtx-to-develop-gene-therapy-programs-for-inherited-retinal-diseases/ 2019-02-01T10:53:21+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/MeiraGTx-Logo.jpg http://www.pharmajournalist.com/genentech-to-discontinue-phase-iii-cread-1-and-2-clinical-studies-of-crenezumab-in-early-alzheimers-disease-ad/ 2019-02-01T10:57:58+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Genentech-Logo.jpg http://www.pharmajournalist.com/hitachi-chemical-to-acquire-apceth-biopharma/ 2019-02-01T11:01:51+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Hitachi-Chemicals.jpg http://www.pharmajournalist.com/particle-sciences-partners-with-encube-ethicals-to-develop-novel-vaginal-rings/ 2019-02-01T11:04:38+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Particle-Sciences-Logo.jpg http://www.pharmajournalist.com/cryoport-opens-global-logistics-center-in-amsterdam/ 2019-02-01T11:06:24+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Cryoport-Logo.jpg http://www.pharmajournalist.com/fresenius-kabi-introduces-leucovorin-calcium-injection-usp/ 2019-02-01T11:09:56+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Leucovorin_Injection_Group.jpg https://pharmajournalist.com/wp-content/uploads/2019/02/Leucovorin_Injection_Group.jpg http://www.pharmajournalist.com/sgs-expands-biologics-viral-vaccine-gene-and-cell-therapy-testing/ 2019-02-01T11:15:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/sgs-logo.jpg http://www.pharmajournalist.com/orgenesis-announces-u-s-expansion-of-masthercell-global-subsidiary/ 2019-02-01T11:19:18+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/orgenesis-logo.jpg http://www.pharmajournalist.com/bioduro-partners-with-advent-international/ 2019-02-01T11:21:28+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/agenus-to-launch-the-first-asset-backed-digital-security-offering-in-healthcare/ 2019-02-01T11:25:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agenus.jpg http://www.pharmajournalist.com/takedas-dengue-vaccine-candidate-meets-primary-endpoint-in-pivotal-phase-3-efficacy-trial/ 2019-02-01T11:26:28+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/hear-from-sanofi-and-merck-at-smis-injectable-drug-delivery-2019/ 2019-02-05T10:12:26+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/Injectable-Drug-Delivery-2019_Pharma-Journalist.jpg http://www.pharmajournalist.com/registration-opens-for-smis-4th-pre-filled-syringes-west-coast-2019/ 2019-02-06T09:37:33+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/Pre-Filled-Syringes-East-Coast-Banner-Pharma-Journalist.jpg http://www.pharmajournalist.com/smis-3rd-annual-3d-cell-culture-conference-takes-place-in-only-2-weeks/ 2019-02-07T08:20:07+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/3D-Cell-Culture-Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/fate-therapeutics-announces-fda-clearance-of-ind-application-for-worlds-first-cell-therapy-derived-from-an-engineered-pluripotent-stem-cell/ 2019-02-08T09:08:12+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Fate-Therapeutics-Logo.jpg http://www.pharmajournalist.com/evotec-and-galapagos-enter-into-collaboration-in-the-field-of-fibrosis/ 2019-02-08T09:10:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/evotec.png http://www.pharmajournalist.com/taiho-and-cullinan-oncology-establish-collaboration-to-develop-tas6417-novel-egfr-tyrosine-kinase-inhibitor/ 2019-02-08T09:12:10+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/value-a-balancing-act/ 2019-02-08T09:14:22+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/piggy-bank-seesaw-picture-id499466605.jpg http://www.pharmajournalist.com/a-personal-mission/ 2019-02-08T09:24:11+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/article_eyeforpharma.jpg http://www.pharmajournalist.com/wp-content/uploads/2019/02/article_eyeforpharma.jpg http://www.pharmajournalist.com/reclaim-the-glory-of-value/ 2019-02-08T09:24:22+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/sword-in-the-stone-excalibur.jpg http://www.pharmajournalist.com/wp-content/uploads/2019/02/sword-in-the-stone-excalibur.jpg https://pharmajournalist.com/wp-content/uploads/2019/02/michelle_carnahan.jpg http://www.pharmajournalist.com/xencor-to-develop-and-commercialize-novel-il-15-immune-activating-cytokines-with-genentech/ 2019-02-08T09:46:36+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Xencor_Logo.png http://www.pharmajournalist.com/gsk-signs-4-2bn-immunotherapy-deal-with-the-merck-group/ 2019-02-08T09:48:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/isatuximab-phase-3-trial-meets-primary-endpoint-of-prolonging-progression-free-survival-in-patients-with-relapsed-refractory-multiple-myeloma/ 2019-02-08T09:51:53+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/argenx-and-halozyme-enter-global-collaboration-and-license-agreement-for-enhanze-technology/ 2019-02-08T09:54:54+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/argenx-Logo.jpg http://www.pharmajournalist.com/fda-grants-breakthrough-therapy-designation-for-potential-next-generation-rsv-medicine-medi8897/ 2019-02-08T09:56:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/alkermes-receives-complete-response-letter-from-fda-for-alks-5461-new-drug-application/ 2019-02-08T09:59:16+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Alkermes.png http://www.pharmajournalist.com/moderna-announces-dosing-of-the-first-monoclonal-antibody-encoded-by-mrna-in-a-clinical-trial/ 2019-02-08T10:03:45+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Moderna-Logo.png http://www.pharmajournalist.com/verseon-reports-first-dosing-in-phase-1-trial-on-new-precision-oral-anticoagulant/ 2019-02-08T10:07:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/iqvia-launches-iqvia-biotech-dedicated-to-emerging-biotech-and-biopharma-industry/ 2019-02-08T10:23:48+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/IQVIA-Logo.png http://www.pharmajournalist.com/ligand-announces-omniab-partnership-with-genagon-therapeutics/ 2019-02-08T10:28:49+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Ligand-Pharmaceuticals-logo.png http://www.pharmajournalist.com/tamrx-launches-to-develop-pipeline-of-immuno-oncology-products-for-treatment-of-cancers/ 2019-02-08T10:32:11+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/BioMotiv-Logo.jpg http://www.pharmajournalist.com/newron-completes-patient-enrollment-in-pivotal-stars-study/ 2019-02-08T10:38:46+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Newron_Logo.png http://www.pharmajournalist.com/pathios-therapeutics-and-sygnature-discovery-sign-strategic-partnership/ 2019-02-08T10:45:04+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Sygnature-discovery-logo.jpg http://www.pharmajournalist.com/genequantum-and-mitro-enter-into-strategic-cooperation-to-develop-next-generation-radionuclide-conjugates/ 2019-02-08T10:48:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/trevi-announces-license-agreements-for-use-of-nalbuphine-for-the-treatment-of-lid-in-parkinsons-disease/ 2019-02-08T10:50:34+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/trevi-therapeutics-logo.png http://www.pharmajournalist.com/taiho-and-cullinan-oncology-establish-collaboration-to-develop-tas6417-novel-egfr-tyrosine-kinase-inhibitor-2/ 2019-02-08T10:52:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/novelion-therapeutics-subsidiary-enters-into-licensing-agreement-for-juxtapid-in-japan/ 2019-02-08T10:56:28+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Novelion-Therapeutics-Logo.png http://www.pharmajournalist.com/cannabics-and-wize-pharma-to-form-joint-venture-to-develop-cannabinoid-based-ophthalmic-therapeutics/ 2019-02-08T11:00:02+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Cannabics-Logo.jpg http://www.pharmajournalist.com/dhariya-mehta-from-shire-shares-his-views-on-the-future-of-pre-filled-syringes/ 2019-02-08T11:36:46+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/Pre-Filled-Syringes-East-Coast-Banner-Pharma-Journalist.jpg http://www.pharmajournalist.com/latest-developments-in-combating-antifungal-resistance-to-be-discussed-by-industry-leaders-at-superbugs-superdrugs-conference-in-london/ 2019-02-12T06:57:24+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Superbugs-Superdrugs-2018-Banner-Pharma-Journalist.jpg http://www.pharmajournalist.com/explore-the-role-of-data-science-and-informatics-at-adaptive-designs-in-clinical-trials-conference-2019/ 2019-02-12T10:39:09+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Adaptive-Design-in-Clincal-Trials-Phama-Journalist.jpg http://www.pharmajournalist.com/exclusive-insights-into-the-latest-innovations-at-drug-discovery-chemistry/ 2019-02-14T16:21:56+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Drug-Discovery-Chemistry-Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/hear-exclusive-insights-from-leading-microbiologists-at-smis-pharmaceutical-microbiology-east-coast-event/ 2019-02-15T06:37:51+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/Pharma-Micro-East-Coast-2019-Pharma-Journalist.jpg http://www.pharmajournalist.com/sk-biopharmaceuticals-and-arvelle-therapeutics-announce-agreement-to-develop-and-commercialize-cenobamate-in-europe/ 2019-02-15T08:26:55+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/SK-Biopharmaceuticals-Logo.png http://www.pharmajournalist.com/abcellera-announces-multi-target-partnership-agreement-with-a-top-5-global-pharma/ 2019-02-15T08:28:53+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/AbCellera-Logo.jpg http://www.pharmajournalist.com/neurogene-raises-68-5-million-in-series-a-financing-to-advance-multiple-programs-in-devastating-neurological-diseases/ 2019-02-15T08:31:17+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Neurogene-Logo.png http://www.pharmajournalist.com/fda-advisory-committee-recommends-approval-of-spravato-esketamine-nasal-spray-ciii-for-adults-with-treatment-resistant-depression/ 2019-02-15T08:34:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/novartis-receives-fda-approval-for-egaten-for-the-treatment-of-fascioliasis-a-neglected-tropical-disease/ 2019-02-15T08:37:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/merck-increases-focus-on-advanced-prostate-cancer-expanding-immuno-oncology-program-with-three-new-phase-3-trials/ 2019-02-15T08:40:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/abbvie-and-teneobio-announce-a-strategic-transaction-to-develop-a-new-treatment-for-multiple-myeloma/ 2019-02-15T08:42:31+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/ucb-and-epilepsy-society-announce-pioneering-uk-genomics-rd-collaboration/ 2019-02-15T08:44:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/ucb-pharma.jpg http://www.pharmajournalist.com/regeneron-and-sanofi-offer-praluent-alirocumab-at-a-new-reduced-u-s-list-price/ 2019-02-15T08:48:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/regeneron.jpg http://www.pharmajournalist.com/abilita-bio-and-amgen-enter-into-a-multi-target-collaboration/ 2019-02-15T08:52:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/jubilant-biosys-expands-collaboration-with-sanofi-in-cns-therapeutic-area/ 2019-02-15T09:01:14+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Jubilant-Biosys-Logo.jpg http://www.pharmajournalist.com/moberg-pharma-and-bayer-sign-exclusive-license-agreement-for-mob-015-in-europe/ 2019-02-15T09:30:28+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/bayer.jpg http://www.pharmajournalist.com/regenerxs-u-s-joint-venture-initiates-key-phase-3-dry-eye-clinical-trial-with-rgn-259/ 2019-02-15T09:32:55+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/RegeneRx-Logo.jpg http://www.pharmajournalist.com/3sbio-and-verseau-establish-global-clinical-development-collaboration-for-first-in-class-immuno-oncology-therapies/ 2019-02-15T09:43:04+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/3Sbio-Logo.png http://www.pharmajournalist.com/wuxi-biologics-and-amicus-sign-exclusive-manufacturing-partnership/ 2019-02-15T09:44:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/wuxi-biologics-logo.png http://www.pharmajournalist.com/emerald-health-pharmaceuticals-and-lonza-announce-agreement-for-manufacturing-of-novel-cannabinoid-derived-drug-candidate/ 2019-02-15T09:47:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/lonza.jpg http://www.pharmajournalist.com/sgs-to-conduct-its-first-malaria-human-challenge-trial-in-belgium/ 2019-02-15T09:52:39+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/sgs-logo.jpg http://www.pharmajournalist.com/amyris-is-selected-by-nih-grant-recipient-idri-to-engineer-molecules-for-vaccine-adjuvant-applications/ 2019-02-15T09:54:34+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/amyris-logo.jpg http://www.pharmajournalist.com/boehringer-and-lillys-carolina-cardiovascular-outcome-trial-for-trajenta-meets-primary-endpoint-of-non-inferiority-compared-to-glimepiride/ 2019-02-15T09:57:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Boehringer-Ingelheim.jpg http://www.pharmajournalist.com/eton-pharmaceuticals-enters-into-license-agreement-for-two-branded-hospital-product-candidates/ 2019-02-15T10:00:35+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/ETON_Pharma_Logo.png http://www.pharmajournalist.com/mayne-pharma-launches-lexette-tm-halobetasol-propionate-foam-0-05-in-the-united-states/ 2019-02-15T10:04:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/mayne-pharma.jpg http://www.pharmajournalist.com/recipharm-announces-all-its-facilities-are-ready-for-eu-serialisation/ 2019-02-15T10:05:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/recipharm.jpg http://www.pharmajournalist.com/amgen-and-gsk-to-present-on-regulatory-updates-and-patient-safety-at-injectable-drug-delivery-2019/ 2019-02-19T10:58:18+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/Injectable-Drug-Delivery-2019_Pharma-Journalist.jpg http://www.pharmajournalist.com/pre-filled-syringes-chemical-compatibility-and-design-strategies/ 2019-02-20T11:55:00+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/Pre-Filled-Syringes-East-Coast-Banner-Pharma-Journalist.jpg http://www.pharmajournalist.com/smis-pharma-microbiology-west-coast-2019-chair-and-speakers-announced/ 2019-02-21T15:12:55+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Pharmaceutical-Microbiology-West-Coast_PJ.jpg http://www.pharmajournalist.com/xencor-announces-partial-clinical-hold-on-phase-1-study-of-xmab14045/ 2019-02-22T08:19:17+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Xencor_Logo.png http://www.pharmajournalist.com/biomx-raises-32-million-in-series-b-financing/ 2019-02-22T08:21:47+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/biomxlogo.png http://www.pharmajournalist.com/novo-nordisk-receives-fda-approval-of-esperoct-turoctocog-alfa-pegol-n8-gp/ 2019-02-22T08:23:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/novo-nordisk-logo.jpg http://www.pharmajournalist.com/abbott-and-novo-nordisk-enter-partnership-to-provide-integrated-digital-solution-to-people-with-diabetes-using-insulin/ 2019-02-22T08:25:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Abbott1.png http://www.pharmajournalist.com/ochsner-health-system-and-pfizer-partner-to-develop-innovative-models-for-clinical-trials/ 2019-02-22T08:28:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/pfizer-and-lilly-announce-top-line-results-from-phase-3-study-of-tanezumab-in-chronic-low-back-pain/ 2019-02-22T08:31:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/indivior-announces-launch-of-suboxone-buprenorphine-and-naloxone-sublingual-film-authorized-generic/ 2019-02-22T08:32:52+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Indivior-logo.png http://www.pharmajournalist.com/fda-agrees-to-review-abbvies-upadacitinib-in-rheumatoid-arthritis/ 2019-02-22T08:35:26+00:00 https://pharmajournalist.com/wp-content/uploads/2018/04/abbvie-logo.jpg http://www.pharmajournalist.com/knight-therapeutics-and-triumvira-immunologics-triumphantly-announce-secured-bridge-loan-license-agreement/ 2019-02-22T08:37:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/fda-grants-priority-review-to-genentechs-polatuzumab-vedotin-in-previously-treated-aggressive-lymphoma/ 2019-02-22T08:41:20+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Genentech-Building.jpeg http://www.pharmajournalist.com/fda-grants-priority-review-to-genentechs-personalized-medicine-entrectinib/ 2019-02-22T08:42:43+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Genentech-Building.jpeg http://www.pharmajournalist.com/new-organ-sparing-radiotherapy-plan-could-reduce-treatment-side-effects/ 2019-02-22T08:46:20+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/seminoma_testes.jpg https://pharmajournalist.com/wp-content/uploads/2019/02/seminoma_testes.jpg http://www.pharmajournalist.com/innovent-announces-a-collaboration-with-chipscreen-biosciences-to-evaluate-the-combination-therapy-in-colorectal-cancer-patients/ 2019-02-22T08:48:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/merck-receives-first-u-s-patent-for-improved-crispr-genome-editing-method/ 2019-02-22T08:51:45+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/proxy-CRISPR.jpg https://pharmajournalist.com/wp-content/uploads/2019/02/proxy-CRISPR.jpg http://www.pharmajournalist.com/lilly-completes-acquisition-of-loxo-oncology/ 2019-02-22T08:54:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/morphic-therapeutic-enters-into-integrin-research-and-development-collaboration-with-janssen/ 2019-02-22T08:56:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/torque-announces-clinical-trial-collaboration-with-merck/ 2019-02-22T08:59:04+00:00 https://pharmajournalist.com/wp-content/uploads/2018/08/Torque-Logo.png http://www.pharmajournalist.com/nanosphere-signs-definitive-licensing-agreement-in-oregon/ 2019-02-22T09:00:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/aucta-pharmaceuticals-and-oakrum-pharma-announce-product-development-and-commercialization-partnership/ 2019-02-22T09:11:22+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Aucta-Pharmaceuticals-Logo.jpg http://www.pharmajournalist.com/exicure-announces-license-and-development-agreement-with-dermelix-biotherapeutics-in-rare-genetic-skin-diseases/ 2019-02-22T09:14:00+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Exicure_Logo.jpg http://www.pharmajournalist.com/qiagen-partners-with-ares-genetics-to-advance-global-fight-against-antibiotic-resistant-pathogens/ 2019-02-22T09:15:22+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/qiagen-image.jpg http://www.pharmajournalist.com/wuxi-sta-and-biolingus-sign-exclusive-technology-and-marketing-collaboration-for-sublingual-delivery/ 2019-02-22T09:16:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/fda-grants-priority-review-to-roches-polatuzumab-vedotin-in-previously-treated-aggressive-lymphoma/ 2019-02-22T09:19:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/fda-grants-priority-review-to-roches-personalised-medicine-entrectinib/ 2019-02-22T09:20:01+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/5-leaders-1-panel-microbiome-movement-drug-development-summit/ 2019-02-25T14:28:56+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Microbiome-Drug-Development-Boston_Pharma-Journalist-Banner.png http://www.pharmajournalist.com/seize-the-strategic-market-of-the-livestock-industry-and-build-an-integrated-professional-platform-for-veterinary-drugs/ 2019-02-26T07:17:44+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/AH1.png http://www.pharmajournalist.com/wp-content/uploads/2019/02/AH1.png http://www.pharmajournalist.com/wp-content/uploads/2019/02/AH2.png http://www.pharmajournalist.com/wp-content/uploads/2019/02/AH3.png http://www.pharmajournalist.com/wp-content/uploads/2019/02/a.jpg http://www.pharmajournalist.com/nex-china-takes-the-express-for-healthy-food-together-with-natural-extract-enterprises/ 2019-02-26T07:26:06+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/03.png https://pharmajournalist.com/wp-content/uploads/2019/02/01.jpg https://pharmajournalist.com/wp-content/uploads/2019/02/02.jpg https://pharmajournalist.com/wp-content/uploads/2019/02/03.png http://www.pharmajournalist.com/conference-co-chairs-from-medimmune-ferring-pharmaceuticals-invites-you-to-attend-pre-filled-syringes-west-coast-2019/ 2019-02-26T10:52:59+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Pre-Filled-Syringes-West-Coast_Pharma-Journalist.jpg http://www.pharmajournalist.com/co-chairs-centrexion-therapeutics-metys-pharmaceuticals-invite-to-smis-19th-annual-pain-therapeutics/ 2019-02-27T07:46:55+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/PainTherapeutics_Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/less-than-3-weeks-to-smis-3rd-annual-drug-discovery-chemistry-conference/ 2019-02-28T11:54:09+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Drug-Discovery-Chemistry-Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/abpro-and-njcttq-enter-into-partnership-for-development-of-multiple-novel-bispecific-antibodies/ 2019-03-01T09:08:55+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/abpro-therapeutics-logo.png http://www.pharmajournalist.com/abcellera-and-denali-sign-expanded-multi-year-multi-target-deal-to-discover-therapeutic-antibodies-for-neurological-diseases/ 2019-03-01T09:11:56+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/AbCellera-Logo.jpg http://www.pharmajournalist.com/sarepta-exercises-option-to-acquire-myonexus-therapeutics/ 2019-03-01T09:15:46+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Sarepta-Therapeutics.jpg http://www.pharmajournalist.com/genesis-drug-discovery-development-announces-operating-agreement-with-ophthy-ds/ 2019-03-01T09:18:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/selexis-sa-and-turgut-expand-biosimilar-development-relationship-by-signing-two-commercial-license-agreements/ 2019-03-01T09:20:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/selexis-logo.jpg http://www.pharmajournalist.com/imbrium-and-tetragenetics-announce-strategic-research-collaboration-and-license-option-to-develop-novel-biologic-therapeutics-for-pain/ 2019-03-01T09:23:27+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/Imbrium-logo.png http://www.pharmajournalist.com/titan-pharmaceuticals-partners-with-alliancerx-walgreens-prime-specialty-pharmacy-to-expand-patient-access-to-probuphine/ 2019-03-01T09:25:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/TITAN-Pharma-logo.png http://www.pharmajournalist.com/mallinckrodt-announces-extracorporeal-photopheresis-research-collaboration-agreement-with-transimmune/ 2019-03-01T09:26:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/mallinckrodt-pharma.jpg http://www.pharmajournalist.com/abbvie-and-voyager-announce-collaboration-to-develop-vectorized-antibodies-to-treat-parkinsons-disease-and-other-synucleinopathies/ 2019-03-01T09:28:50+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/maze-therapeutics-launches-with-191-million-to-focus-on-translating-genetic-insights-into-new-medicines/ 2019-03-01T09:34:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/drug-discovery.jpg http://www.pharmajournalist.com/lynparza-significantly-delayed-disease-progression-as-1st-line-maintenance-treatment-in-germline-brca-mutated-metastatic-pancreatic-cancer/ 2019-03-01T09:40:59+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/brilintas-phase-iii-themis-trial-met-primary-endpoint-in-patients-with-established-coronary-artery-disease-and-type-2-diabetes/ 2019-03-01T09:42:30+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/fda-approves-herceptin-hylecta-for-subcutaneous-injection-in-certain-her2-positive-breast-cancers/ 2019-03-01T09:45:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/novartis-to-pursue-transformational-therapy-to-reduce-risk-of-cardiovascular-disease-in-people-living-with-elevated-levels-of-inherited-lipoproteina/ 2019-03-01T09:57:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/ipsen-to-acquire-clementia-pharmaceuticals-to-significantly-boost-rare-disease-portfolio/ 2019-03-01T09:59:21+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Ipsen-Group-Image.jpg http://www.pharmajournalist.com/urovant-sciences-enters-into-flexible-agreement-for-up-to-100-million-debt-financing-with-hercules-capital/ 2019-03-01T10:00:37+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/amgen-cytokinetics-and-servier-announce-start-of-meteoric-hf-the-second-phase-3-clinical-trial-of-omecamtiv-mecarbil-in-patients-with-heart-failure/ 2019-03-01T10:03:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/apellis-announces-collaboration-with-sfj-pharmaceuticals-for-apl-2-in-hematologic-indications/ 2019-03-01T10:06:32+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/Apellis-Pharma-Logo.jpg http://www.pharmajournalist.com/pfenex-and-alvogen-expand-development-and-commercialization-collaboration-for-pf708/ 2019-03-01T10:09:55+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/Alvogen-Logo.jpg http://www.pharmajournalist.com/parexel-expands-oncology-expertise-through-fda-and-medical-oncologist-appointments/ 2019-03-01T10:12:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/parexel-clinical.jpg http://www.pharmajournalist.com/amicus-establishes-global-research-and-gene-therapy-center-of-excellence-in-philadelphia/ 2019-03-01T10:14:23+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Amicus-Therapeutics-Logo.jpg http://www.pharmajournalist.com/cepi-awards-us-34m-contract-to-curevac-to-advance-the-rna-printer/ 2019-03-01T10:18:42+00:00 https://pharmajournalist.com/wp-content/uploads/2018/03/Curevac-logo.png http://www.pharmajournalist.com/industry-experts-to-discuss-containment-solutions-and-adc-developments-at-highly-potent-active-pharmaceutical-ingredients-hpapi-2019/ 2019-03-01T12:29:40+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/HAPAPI-Banner-SMi-Pharma-Journalist.jpg http://www.pharmajournalist.com/exclusive-speaker-interview-released-with-sumitomo-rubber-ahead-of-pre-filled-syringes-west-coast-2019/ 2019-03-05T10:25:00+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Pre-Filled-Syringes-West-Coast_Pharma-Journalist.jpg http://www.pharmajournalist.com/four-weeks-until-smis-11th-annual-adaptive-designs-in-clinical-trials-conference-in-london/ 2019-03-05T11:24:44+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/Adaptive-Design-in-Clincal-Trials-Phama-Journalist.jpg http://www.pharmajournalist.com/senior-industry-experts-to-discuss-recent-developments-in-bacterial-immunotherapy-at-superbugs-superdrugs-2019/ 2019-03-05T12:37:04+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Superbugs-Superdrugs-2018-Banner-Pharma-Journalist.jpg http://www.pharmajournalist.com/interview-released-with-reckitt-benckiser-speaker-at-pain-therapeutics-2019/ 2019-03-07T10:14:53+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/PainTherapeutics_Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/beam-therapeutics-secures-135-million-to-advance-crispr-technologies/ 2019-03-08T09:49:15+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/Beam-Therapeutics-Logo.jpg http://www.pharmajournalist.com/fda-grants-priority-review-for-fedratinib-new-drug-application-in-myelofibrosis/ 2019-03-08T09:53:41+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/celgene-corporation.jpg http://www.pharmajournalist.com/two-phase-3-studies-of-the-triple-combination-of-vx-445-tezacaftor-and-ivacaftor-met-primary-endpoint-of-improvement-in-lung-function-ppfev1-in-people-with-cystic-fibrosis/ 2019-03-08T09:55:24+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Vertex.jpg http://www.pharmajournalist.com/antolrx-announces-pfizer-exercises-option-to-license-immune-tolerance-therapy-for-potential-treatment-of-type-1-diabetes/ 2019-03-08T10:02:09+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/bayer-submits-european-marketing-authorization-application-for-darolutamide/ 2019-03-08T10:05:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/bayer.jpg http://www.pharmajournalist.com/bayer-submits-darolutamide-for-marketing-authorization-in-japan/ 2019-03-08T10:09:26+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/bayer.jpg http://www.pharmajournalist.com/nantkwest-signs-worldwide-license-agreement-with-promab-biotechnologies-to-exclusively-develop-select-next-generation-targeted-natural-killer-cell-therapeutics/ 2019-03-08T10:11:27+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/NantKwest-Logo.jpg http://www.pharmajournalist.com/gtx-and-oncternal-therapeutics-enter-into-definitive-merger-agreement/ 2019-03-08T10:17:11+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/GTX-logo.jpg http://www.pharmajournalist.com/reform-biologics-announces-collaboration-agreement-with-astellas-pharma/ 2019-03-08T10:19:59+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/ReForm-Biologics-Logo.jpg http://www.pharmajournalist.com/pacira-to-acquire-myoscience-adding-fda-approved-ioverao-system-for-non-opioid-pain-control/ 2019-03-08T10:50:41+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/Pacira-Logo.png http://www.pharmajournalist.com/medexus-enters-into-expanded-licensing-agreement-for-gliolan-in-canada/ 2019-03-08T10:57:32+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/Medexus-Pharma-Logo.jpg http://www.pharmajournalist.com/biogen-announces-agreement-to-acquire-nightstar-therapeutics-to-establish-clinical-pipeline-of-gene-therapy-candidates-in-ophthalmology-2/ 2019-03-08T10:59:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Biogen-logo.jpg http://www.pharmajournalist.com/novo-nordisk-ozempic-superior-in-lowering-blood-sugar-and-weight-vs-placebo-both-in-combination-with-sglt-2-inhibitors/ 2019-03-08T11:02:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/novo-nordisk-logo.jpg http://www.pharmajournalist.com/robust-approaches-to-advance-pre-filled-syringe-development/ 2019-03-08T11:04:04+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/Pre-Filled-Syringes-East-Coast-Banner-Pharma-Journalist.jpg http://www.pharmajournalist.com/novartis-data-confirm-rapid-response-and-high-efficacy-of-cosentyx-in-psoriasis-patients-for-first-time-in-china/ 2019-03-08T11:07:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/gilead-announces-data-from-two-studies-supporting-further-development-of-gs-6207-a-novel-investigational-hiv-1-capsid-inhibitor-as-a-component-of-future-long-acting-hiv-therapies/ 2019-03-08T11:18:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/pfizers-lung-cancer-drug-lorviqua-recommended-for-marketing-authorization-in-eu/ 2019-03-08T11:22:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/sagent-pharmaceuticals-announces-acquisition-of-raleigh-manufacturing-site/ 2019-03-08T11:24:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/potential-new-treatment-for-heart-attack/ 2019-03-08T11:30:05+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/Domainex-Logo.png http://www.pharmajournalist.com/adult-stem-cell-derived-kidney-on-a-chip-in-nature-biotechnology/ 2019-03-08T11:33:00+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/Pic.png http://www.pharmajournalist.com/wp-content/uploads/2019/03/Pic.png http://www.pharmajournalist.com/sartorius-stedim-biotech-and-novasep-to-develop-novel-systems-for-membrane-chromatography/ 2019-03-08T11:35:41+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/Sartorius-Stedim-Biotech.jpg http://www.pharmajournalist.com/novago-therapeutics-raises-chf-10-million-to-develop-regenerative-anti-nogo-therapy-for-stroke/ 2019-03-08T11:37:51+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/NovaGo-Therapeutics-Logo.png http://www.pharmajournalist.com/lyophilisation-the-latest-strategies-and-new-technologies/ 2019-03-11T08:00:45+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/300x250-1.jpg http://www.pharmajournalist.com/conference-chair-from-medincell-invites-you-to-attend-injectable-drug-delivery-conference-2019/ 2019-03-12T09:29:50+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/Injectable-Drug-Delivery-2019_Pharma-Journalist.jpg http://www.pharmajournalist.com/germany-joins-carb-x-partnership-in-the-fight-against-deadly-drug-resistant-superbugs/ 2019-03-15T11:48:27+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/CARB-X-Logo.jpg http://www.pharmajournalist.com/ec-approves-roches-hemlibra-for-people-with-severe-haemophilia-a-without-factor-viii-inhibitors/ 2019-03-15T11:51:00+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/european-commission-approves-roches-mabthera-rituximab-for-a-rare-autoimmune-disease/ 2019-03-15T11:52:42+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/existing-drug-found-to-dampen-chemo-side-effects-in-breast-cancer-in-a-dish/ 2019-03-15T11:55:20+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/cardiomyocyte.png http://www.pharmajournalist.com/wp-content/uploads/2019/03/cardiomyocyte.png http://www.pharmajournalist.com/deerfield-commits-100m-to-create-alliance-with-harvard/ 2019-03-15T11:59:19+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/013019_Sanes_1882500.jpg https://pharmajournalist.com/wp-content/uploads/2019/03/013019_Sanes_1882500.jpg http://www.pharmajournalist.com/fda-approves-pfizers-oncology-biosimilar-trazimera-trastuzumab-qyyp-a-biosimilar-to-herceptin-1/ 2019-03-15T12:02:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/biogen-enters-into-an-agreement-to-sell-its-large-scale-biologics-manufacturing-site-in-hillerod-denmark-to-fujifilm/ 2019-03-15T12:04:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/Biogen-logo.jpg http://www.pharmajournalist.com/seres-therapeutics-announces-microbiome-immuno-oncology-focused-collaboration-with-astrazeneca/ 2019-03-15T12:05:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astrazeneca.jpg http://www.pharmajournalist.com/who-launches-new-global-influenza-strategy/ 2019-03-15T12:07:58+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/Influenza.jpg http://www.pharmajournalist.com/kitov-to-acquire-clinical-stage-candidate-cm-24-creating-a-transformational-immuno-oncology-company/ 2019-03-15T12:12:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/drug.jpg http://www.pharmajournalist.com/flow-pharma-and-oncoimmunity-as-partner-for-the-development-of-flowvax-personalized-cancer-vaccines/ 2019-03-15T12:15:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/hoth-enters-into-commercial-licensing-agreement-with-university-of-maryland-baltimore-and-isoprene/ 2019-03-15T12:17:44+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/x4-pharmaceuticals-completes-merger-with-arsanis/ 2019-03-15T12:20:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/secura-bio-acquires-global-rights-to-farydak/ 2019-03-15T12:24:57+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/Secura-Bio-LOgo.png http://www.pharmajournalist.com/tenax-therapeutics-enrolls-first-patient-for-phase-2-pulmonary-hypertension-clinical-trial/ 2019-03-15T12:27:50+00:00 https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical.jpg http://www.pharmajournalist.com/xencor-announces-closing-of-research-collaboration-and-license-agreement-with-genentech/ 2019-03-15T12:29:11+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Xencor_Logo.png http://www.pharmajournalist.com/esperion-announces-publication-of-bempedoic-acid-study-1-results-in-the-new-england-journal-of-medicine/ 2019-03-15T12:32:09+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/Esperion-Logo.jpg http://www.pharmajournalist.com/iktos-announces-collaboration-with-merck-for-use-of-iktos-ai-technology-across-three-drug-discovery-projects/ 2019-03-15T12:34:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/merck-group.jpg http://www.pharmajournalist.com/fda-approves-dupixent-dupilumab-for-moderate-to-severe-atopic-dermatitis-in-adolescents/ 2019-03-15T12:38:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/xeris-doses-first-patient-in-phase-2-trial-evaluating-its-ready-to-use-glucagon-to-address-exercise-induced-hypoglycemia/ 2019-03-15T12:43:16+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/Xeris-Logo.jpg http://www.pharmajournalist.com/bioarctic-announces-start-of-phase-1-study-of-abbv-0805-for-parkinsons-disease/ 2019-03-15T12:44:49+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/clinical-trials.jpg http://www.pharmajournalist.com/pharmaceutics-international-receives-eir-from-fda/ 2019-03-15T12:47:20+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/Pii-Logo.jpg http://www.pharmajournalist.com/agenus-milestone-triggers-7-5m-payment-from-gilead/ 2019-03-15T12:50:28+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/agenus-logo.jpg http://www.pharmajournalist.com/highlighting-advantages-of-the-whole-industry-chain-layout-starting-the-new-journey-of-internationalization-of-pharmaceuticals/ 2019-03-19T06:51:26+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/China-Pharma-Week.jpg https://pharmajournalist.com/wp-content/uploads/2019/03/CPhI-P-MEC-China-2018%E2%95%A7%E2%95%93%E2%94%82%C3%AD%E2%95%9A%E2%95%A6%E2%95%90%E2%95%96%E2%95%98%E2%96%84%E2%95%A2%C2%BB.jpg https://pharmajournalist.com/wp-content/uploads/2019/03/%E2%95%95%E2%81%BF%E2%95%A2%CE%B1%E2%95%91%C3%BA%E2%95%90%CE%93%E2%95%99%E2%94%BC%E2%95%93%E2%95%A9%E2%95%92%E2%95%A3%E2%95%90%E2%94%BC%E2%95%A5%E2%95%A4%E2%95%9A%CE%B4%E2%95%AB%C3%B1.jpg https://pharmajournalist.com/wp-content/uploads/2019/03/China-Pharma-Week.jpg http://www.pharmajournalist.com/10-key-reasons-to-attend-smis-2nd-annual-pharmaceutical-microbiology-east-coast/ 2019-03-21T09:28:38+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/P-296-Pharma-Micro-EC-Chair-Banner-for-James-Drinkswater.jpg http://www.pharmajournalist.com/wp-content/uploads/2019/03/P-296-Pharma-Micro-EC-Chair-Banner-for-James-Drinkswater.jpg http://www.pharmajournalist.com/smis-hpapi-2019-conference-exclusive-interview-released-with-astrazeneca/ 2019-03-21T12:22:53+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/HAPAPI-Banner-SMi-Pharma-Journalist.jpg http://www.pharmajournalist.com/the-pharma-gorilla-will-be-held-on-march-27-2019-in-hilton-mumbai-international-airport-mumbai-india/ 2019-03-22T08:17:49+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/pharma-journalist.png http://www.pharmajournalist.com/wp-content/uploads/2019/03/pharma-journalist.png http://www.pharmajournalist.com/pfizer-secures-exclusive-option-to-acquire-gene-therapy-company-vivet-therapeutics/ 2019-03-22T08:28:16+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/merck-and-ngm-bio-announce-extension-of-broad-multi-year-strategic-collaboration-to-2022/ 2019-03-22T08:31:18+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/merck.jpg http://www.pharmajournalist.com/data-from-garnet-study-indicates-robust-activity-of-dostarlimab-in-patients-with-advanced-or-recurrent-endometrial-cancer/ 2019-03-22T08:33:35+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/gsk.jpg http://www.pharmajournalist.com/gsk-announces-further-positive-data-from-dreamm-1-study-of-anti-bcma-antibody-drug-conjugate-in-patients-with-relapsed-refractory-multiple-myeloma/ 2019-03-22T08:35:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/gsk.jpg http://www.pharmajournalist.com/sage-therapeutics-announces-fda-approval-of-zulresso-brexanolone-injection/ 2019-03-22T08:39:02+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/Sage-Therapeutics-Logo.jpg http://www.pharmajournalist.com/fda-approves-roches-tecentriq-in-combination-with-chemotherapy-for-the-initial-treatment-of-adults-with-extensive-stage-small-cell-lung-cancer/ 2019-03-22T08:42:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/roche-pharma.jpg http://www.pharmajournalist.com/allergan-announces-fda-approval-of-avycaz-ceftazidime-and-avibactam-for-pediatric-patients/ 2019-03-22T09:39:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/allergan.jpg http://www.pharmajournalist.com/boehringer-ingelheim-announces-fda-and-ema-regulatory-submission-for-nintedanib-in-systemic-sclerosis-associated-ild/ 2019-03-22T09:41:23+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/boehringer-ingelheim.jpg http://www.pharmajournalist.com/novo-nordisk-settles-us-patent-litigation-case-on-victoza-liraglutide-with-teva/ 2019-03-22T09:43:03+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/novo-nordisk-logo.jpg http://www.pharmajournalist.com/evotec-and-gardp-announce-new-partnership-to-discover-novel-antibiotics/ 2019-03-22T09:44:41+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/evotec.png http://www.pharmajournalist.com/alexion-and-affibody-announce-partnership-to-co-develop-anti-fcrn-affibody-molecule/ 2019-03-22T09:48:33+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Alexion-Pharma-Logo.png http://www.pharmajournalist.com/biologics-by-mckesson-expands-specialty-pharmacy-capabilities-to-serve-patients-with-rare-and-complex-conditions/ 2019-03-22T09:50:13+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/McKesson-Logo.jpg http://www.pharmajournalist.com/takeda-and-hemoshear-therapeutics-extend-exclusive-drug-discovery-partnership-in-liver-diseases/ 2019-03-22T09:51:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/petra-pharma-announces-licensing-agreement-with-takeda-pharmaceutical-company/ 2019-03-22T09:53:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/merck-to-collaborate-with-genscript-to-accelerate-cell-and-gene-therapy-industrialization-in-china/ 2019-03-22T09:56:06+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/Merck_GenScript.jpg http://www.pharmajournalist.com/wp-content/uploads/2019/03/Merck_GenScript.jpg http://www.pharmajournalist.com/eastgate-biotech-signs-strategic-alliance-agreement-with-mj-biopharm-for-insulin-api-supply/ 2019-03-22T09:58:58+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/EastGate-Biotech-Logo.jpg http://www.pharmajournalist.com/astellas-and-napajen-establish-research-collaboration-for-discovery-and-development-of-novel-oligonucleotides/ 2019-03-22T10:01:40+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/astellas.jpg http://www.pharmajournalist.com/ono-pharmaceutical-and-twoxar-announce-drug-discovery-research-collaboration/ 2019-03-22T10:04:38+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/twoXAR_Logo.jpg http://www.pharmajournalist.com/mundipharma-announces-launch-of-invokana-and-vokanamet-in-norway-for-the-treatment-of-type-2-diabetes/ 2019-03-22T10:08:25+00:00 https://pharmajournalist.com/wp-content/uploads/2018/10/Mundipharma-Logo.png http://www.pharmajournalist.com/conatus-announces-top-line-results-from-encore-nf-phase-2b-clinical-trial-in-nash-fibrosis/ 2019-03-22T10:11:44+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/Conatus-Pharma-Logo.jpg http://www.pharmajournalist.com/wuxi-biologics-receives-ema-gmp-certificates/ 2019-03-22T10:18:39+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/WuXi-Biologics-Logo.jpg http://www.pharmajournalist.com/milliporesigma-opens-first-m-lab-collaboration-center-in-europe/ 2019-03-22T10:24:41+00:00 http://www.pharmajournalist.com/wp-content/uploads/2019/03/MilliporeSigma-Opens-First-M-Lab.jpg http://www.pharmajournalist.com/5-microbiology-spotlight-sessions-to-be-covered-at-smis-3rd-annual-pharma-microbiology-west-coast/ 2019-03-26T07:35:13+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/Pharma-Micro-WC_Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/smis-2nd-annual-pharmaceutical-microbiology-east-coast-confex-in-2-weeks/ 2019-03-28T07:57:39+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/P-296-Pharma-Micro-EC-Chair-Banner-for-James-Drinkswater.jpg http://www.pharmajournalist.com/novartis-receives-fda-approval-for-mayzent-siponimod-the-first-oral-drug-to-treat-secondary-progressive-ms-with-active-disease/ 2019-03-29T09:02:54+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/regenerx-and-lees-pharm-to-accelerate-rgn-259-development-in-china/ 2019-03-29T09:06:38+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/RegeneRx-Logo.jpg http://www.pharmajournalist.com/abbvie-receives-regulatory-approval-for-plaque-psoriasis-drug-in-japan/ 2019-03-29T09:08:21+00:00 https://pharmajournalist.com/wp-content/uploads/2018/02/Abbvie.jpg http://www.pharmajournalist.com/purdue-pharma-announces-landmark-agreement-with-oklahoma-to-advance-the-treatment-of-addiction/ 2019-03-29T09:09:58+00:00 https://pharmajournalist.com/wp-content/uploads/2018/06/Purdue-Pharma.jpg http://www.pharmajournalist.com/cytodyns-monotherapy-trial-with-leronlimab-pro-140-exceeds-expectations/ 2019-03-29T09:11:48+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/Cytodyn-Logo.jpg http://www.pharmajournalist.com/fda-approves-clarus-jatenzo-as-testosterone-replacement-therapy/ 2019-03-29T09:13:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/FDA.jpg http://www.pharmajournalist.com/lilly-and-immunext-announce-licensing-and-research-collaboration/ 2019-03-29T09:13:36+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/lilly.jpg http://www.pharmajournalist.com/european-phase-3-trial-of-aimmune-therapeutics-ar101-meets-primary-endpoint/ 2019-03-29T09:15:58+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Aimmune-Therapeutics-logo.png http://www.pharmajournalist.com/bayer-receives-positive-opinion-from-european-medicines-agency-for-baycox-iron-injection-for-piglets/ 2019-03-29T09:17:55+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/bayer.jpg http://www.pharmajournalist.com/forxiga-approved-in-europe-for-type-1-diabetes/ 2019-03-29T09:19:21+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/barc-lab-and-owl-metabolomics-announce-strategic-partnership-on-deploying-metabolomic-technology-in-clinical-trials/ 2019-03-29T09:21:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/stridebio-and-takeda-sign-collaboration-and-license-agreement-to-advance-novel-gene-therapies-for-neurological-diseases/ 2019-03-29T09:23:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/Takeda-Office-Canada.jpg http://www.pharmajournalist.com/owc-pharmaceutical-research-corp-to-collaborate-with-sourasky-medical-center-in-tel-aviv-for-a-safety-study-on-its-cannabis-based-tablets/ 2019-03-29T09:28:06+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/OWC_Pharma_Logo.jpg http://www.pharmajournalist.com/immuno-oncology-company-elicio-therapeutics-launches-with-novel-vaccine-immunotherapy-platform-to-treat-an-array-of-cancers/ 2019-03-29T09:31:42+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/Elicio-Therapeutics-Logo.jpg http://www.pharmajournalist.com/bioinvent-and-transgene-extend-their-collaboration-to-develop-multifunctional-oncolytic-viruses-for-the-treatment-of-solid-tumors/ 2019-03-29T09:34:37+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/BioInvest-Logo.png http://www.pharmajournalist.com/vect-horus-enters-into-collaboration-and-license-agreement-with-ono-pharmaceutical/ 2019-03-29T09:39:40+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/Vect_horus-Logo.jpg http://www.pharmajournalist.com/ocello-announces-two-year-agreement-with-merus-to-provide-in-vitro-research-services-for-mcla-158-and-other-undisclosed-biclonics-programs/ 2019-03-29T09:51:42+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/Ocello-Logo.png http://www.pharmajournalist.com/astrazeneca-and-daiichi-sankyo-enter-collaboration-for-novel-her2-targeting-antibody-drug-conjugate/ 2019-03-29T10:02:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/gilead-launches-hepconnect-initiative-to-reduce-hepatitis-c-infections-in-greater-appalachia/ 2019-03-29T10:04:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg http://www.pharmajournalist.com/imbrium-therapeutics-announces-fda-orphan-drug-designation-for-tinostamustine-for-the-treatment-of-t-cell-prolymphocytic-leukemia/ 2019-03-29T10:08:34+00:00 https://pharmajournalist.com/wp-content/uploads/2017/11/drug.jpg http://www.pharmajournalist.com/velicept-therapeutics-announces-positive-top-line-phase-2b-results-for-solabegron-in-the-treatment-of-overactive-bladder-oab/ 2019-03-29T10:11:36+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/Velicept-Logo.jpg http://www.pharmajournalist.com/cook-regentec-launches-profusion-therapeutic-infusion-needle-for-intramuscular-or-subdermal-infusion-of-therapeutic-agents/ 2019-03-29T10:15:17+00:00 https://pharmajournalist.com/wp-content/uploads/2019/03/Cook-Regentec-Logo.jpg http://www.pharmajournalist.com/meet-top-pfs-experts-network-with-100-pharma-and-biotech-industry-leaders-next-week-in-boston/ 2019-03-29T10:35:17+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/Pre-Filled-Syringes-East-Coast-Banner-Pharma-Journalist.jpg http://www.pharmajournalist.com/userwise-to-lead-a-post-conference-workshop-at-pre-filled-syringes-west-coast-2019/ 2019-03-29T12:57:20+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Pre-Filled-Syringes-West-Coast_Pharma-Journalist.jpg http://www.pharmajournalist.com/exclusive-speaker-interviews-with-merck-and-sanofi-released-for-injectable-drug-delivery-2019/ 2019-03-29T13:05:07+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/Injectable-Drug-Delivery-2019_Pharma-Journalist.jpg http://www.pharmajournalist.com/viiv-healthcare-announces-juluca-maintains-hiv-viral-suppression-out-to-three-years/ 2019-04-05T07:46:24+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/VIIV-Healthcare-Logo.jpg http://www.pharmajournalist.com/nih-begins-first-in-human-trial-of-a-universal-influenza-vaccine-candidate/ 2019-04-05T07:48:51+00:00 http://www.pharmajournalist.com/wp-content/uploads/2019/04/NIH-vaccine.jpg http://www.pharmajournalist.com/dyne-therapeutics-launches-with-50-million-series-a-to-develop-targeted-therapies-for-muscle-diseases/ 2019-04-05T07:51:31+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/Dyne-Therapeutics-Logo.jpg http://www.pharmajournalist.com/editas-and-bluerock-enter-strategic-research-collaboration-and-cross-licensing-agreement-to-combine-genome-editing-and-cell-therapy-platforms/ 2019-04-05T07:53:32+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/Editas-Medicine-Logo.png http://www.pharmajournalist.com/fda-approves-ibrance-palbociclib-for-the-treatment-of-men-with-hr-her2-metastatic-breast-cancer/ 2019-04-05T07:55:25+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/sangamo-and-pfizer-announce-phase-1-2-interim-data-for-investigational-hemophilia-a-gene-therapy/ 2019-04-05T07:57:29+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/sandoz-resubmits-biosimilar-pegfilgrastim-application-to-us-fda/ 2019-04-05T08:01:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/puma-biotechnology-and-pierre-fabre-enter-into-exclusive-license-agreement-to-develop-and-commercialize-nerlynx-neratinib-in-europe/ 2019-04-05T08:04:02+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/puma-biotechnology.jpg http://www.pharmajournalist.com/amneal-announces-agreement-with-zentiva-to-divest-creo-pharma/ 2019-04-05T08:06:46+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/Amneal-Pharma.jpg http://www.pharmajournalist.com/selumetinib-granted-us-breakthrough-therapy-designation-in-neurofibromatosis-type-1/ 2019-04-05T08:09:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/novartis-updates-on-the-migraine-collaboration-with-amgen/ 2019-04-05T08:11:08+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/novartis-first-in-class-cosentyx-approved-in-china-for-psoriasis-patients/ 2019-04-05T08:13:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/novartis-adds-clinical-and-preclinical-anti-inflammatory-programs-to-portfolio-with-acquisition-of-ifm-tre/ 2019-04-05T08:15:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/novartis.jpg http://www.pharmajournalist.com/pulmatrix-enters-into-binding-term-sheet-with-cipla-technologies-llc-for-the-development-and-commercialization-of-pulmazole/ 2019-04-05T08:18:05+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Pulmatrix-Logo.jpg http://www.pharmajournalist.com/xencor-and-astellas-enter-collaboration-for-novel-bispecific-antibody-program/ 2019-04-05T08:19:56+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Xencor_Logo.png http://www.pharmajournalist.com/briacell-announces-clinical-trial-collaboration-agreement-with-incyte/ 2019-04-05T08:22:47+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/biracell-logo.png http://www.pharmajournalist.com/que-oncology-launches-phase-ii-trials-in-the-united-states/ 2019-04-05T08:25:56+00:00 https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical.jpg http://www.pharmajournalist.com/fda-clears-the-ind-for-ucartcs1-the-first-allogeneic-car-t-to-treat-multiple-myeloma-patients/ 2019-04-05T08:28:59+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/Cellectis-Logo.png http://www.pharmajournalist.com/roivant-and-sinovant-launch-cytovant-sciences-in-partnership-with-medigene-to-develop-cellular-therapies-in-asia/ 2019-04-05T08:31:36+00:00 https://pharmajournalist.com/wp-content/uploads/2018/09/Roivant_Logo.png http://www.pharmajournalist.com/wcg-announces-the-acquisition-of-analgesic-solutions/ 2019-04-05T08:34:12+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/WCG-Logo.jpg http://www.pharmajournalist.com/sterling-pharma-solutions-announces-acquisition-of-civentichem-in-the-us/ 2019-04-05T08:38:03+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sterling-pharma-solutions.jpg http://www.pharmajournalist.com/proteonic-biotechnology-licenses-protein-production-technology-to-bayer/ 2019-04-05T08:59:27+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/bayer.jpg http://www.pharmajournalist.com/only-four-weeks-left-until-the-2nd-injectable-drug-delivery-conference-in-london/ 2019-04-09T08:59:27+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/Injectable-Drug-Delivery-2019_Pharma-Journalist.jpg http://www.pharmajournalist.com/exclusive-speaker-interviews-with-astrazeneca-ensysce-biosciences-metys-pharmaceuticals-released-for-pain-therapeutics-2019/ 2019-04-10T07:28:21+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/PainTherapeutics_Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/registration-opens-for-smis-9th-annual-conference-on-biobanking-2019/ 2019-04-10T10:05:04+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/Biobanking-Banner-SMi_Pharma-Journalist.jpg http://www.pharmajournalist.com/medstar-health-and-fda-to-lead-a-post-conference-workshop-at-pre-filled-syringes-west-coast-2019/ 2019-04-12T08:57:17+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/Pre-Filled-Syringes-West-Coast_Pharma-Journalist.jpg http://www.pharmajournalist.com/discover-the-future-of-lyophilisation-at-smis-7th-annual-conference-this-june/ 2019-04-12T09:15:30+00:00 https://pharmajournalist.com/wp-content/uploads/2019/02/300x250-1.jpg http://www.pharmajournalist.com/sanofi-and-alnylam-conclude-research-and-option-phase-of-2014-rare-disease-alliance/ 2019-04-12T10:47:17+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Sanofi.jpg http://www.pharmajournalist.com/lynparza-approved-in-eu-for-the-treatment-of-germline-brca-mutated-her2-negative-advanced-breast-cancer/ 2019-04-12T10:48:33+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/astrazeneca-1.jpg http://www.pharmajournalist.com/concerto-healthai-enters-precision-oncology-collaboration-with-pfizer/ 2019-04-12T10:50:53+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/pfizer.jpg http://www.pharmajournalist.com/regeneron-and-alnylam-announce-broad-collaboration-to-discover-develop-and-commercialize-rnai-therapeutics-focused-on-ocular-and-cns-diseases/ 2019-04-12T10:52:57+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/regeneron.jpg http://www.pharmajournalist.com/fda-approves-evenity-romosozumab-aqqg-for-the-treatment-of-osteoporosis-in-postmenopausal-women-at-high-risk-for-fracture/ 2019-04-12T10:56:22+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/amgen.jpg http://www.pharmajournalist.com/centene-and-washington-university-collaborate-to-advance-personalized-medicine-research/ 2019-04-12T10:58:06+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/clinical-trial.jpg http://www.pharmajournalist.com/celgene-corporation-and-acceleron-pharma-announce-submission-of-luspatercept-biologics-license-application-to-fda/ 2019-04-12T11:00:54+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/celgene-corporation.jpg http://www.pharmajournalist.com/twist-bioscience-announces-antibody-optimization-agreement-with-pandion-therapeutics/ 2019-04-12T11:05:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/02/abzena-clinical.jpg http://www.pharmajournalist.com/moleculin-announces-agreement-with-emory-university-to-conduct-pediatric-brain-tumor-trial/ 2019-04-12T11:08:04+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/agreement-signing.png http://www.pharmajournalist.com/i-mab-biopharma-signs-agreement-for-clinical-research-of-tjd5-in-combination-therapy/ 2019-04-12T11:10:39+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/I-Mab-Biopharma-Logo.jpg http://www.pharmajournalist.com/wuxi-biologics-and-nbe-therapeutics-announce-comprehensive-adc-development-and-manufacturing-partnership/ 2019-04-12T11:14:03+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/WuXi-and-NBE-Therapeutics.jpg http://www.pharmajournalist.com/wp-content/uploads/2019/04/WuXi-and-NBE-Therapeutics.jpg http://www.pharmajournalist.com/vifor-pharma-and-akebia-therapeutics-announce-expansion-of-licence-agreement/ 2019-04-12T11:16:11+00:00 https://pharmajournalist.com/wp-content/uploads/2017/05/akebia-pharma-logo.png http://www.pharmajournalist.com/leo-pharma-and-elektrofi-expand-partnership-to-co-develop-new-antibodies-with-the-aim-of-achieving-improvements-in-drug-delivery-within-dermatology/ 2019-04-12T11:17:45+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/leo-pharma.jpg http://www.pharmajournalist.com/ascentage-announces-clinical-collaboration-with-junshi-bioscience-to-evaluate-the-combination-of-apg-1387-and-toripalimab-in-treating-cancers/ 2019-04-12T11:20:04+00:00 https://pharmajournalist.com/wp-content/uploads/2018/12/Ascentage-Pharma.png http://www.pharmajournalist.com/wockhardt-receives-us-fda-approval-for-cancer-drug/ 2019-04-12T11:24:03+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/Wockhardt.jpg http://www.pharmajournalist.com/fda-approves-viiv-healthcares-dovato-dolutegravir-lamivudine-the-first-once-daily-single-tablet-two-drug-regimen-for-treatment-naive-hiv-1-adults/ 2019-04-12T11:26:48+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/VIIV-Healthcare-Logo.jpg http://www.pharmajournalist.com/sun-pharma-launches-ready-to-infuse-infugem-in-the-u-s/ 2019-04-12T11:28:31+00:00 https://pharmajournalist.com/wp-content/uploads/2017/04/SunPharma.jpg http://www.pharmajournalist.com/celularity-selects-cryoports-temperature-controlled-logistics-solutions/ 2019-04-12T11:32:36+00:00 https://pharmajournalist.com/wp-content/uploads/2018/07/Cryoport-Logo.jpg http://www.pharmajournalist.com/fujifilm-announces-the-introduction-of-a-10-week-cell-line-development-timeline-with-its-apollo-x-advanced-mammalian-expression-system/ 2019-04-12T11:35:07+00:00 https://pharmajournalist.com/wp-content/uploads/2017/09/Fujifilm.jpg http://www.pharmajournalist.com/catalent-celebrates-opening-of-second-shanghai-facility-to-optimize-global-and-local-clinical-supply-solutions-for-china/ 2019-04-12T11:36:36+00:00 https://pharmajournalist.com/wp-content/uploads/2018/05/Catalent-Logo.png http://www.pharmajournalist.com/cambrex-completes-highly-potent-api-manufacturing-facility-at-charles-city-ia/ 2019-04-12T11:38:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/08/cambrex-logo.png http://www.pharmajournalist.com/evotec-and-indivumed-announce-strategic-drug-discovery-collaboration-on-precision-medicine-for-colorectal-cancer/ 2019-04-12T11:40:32+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/evotec.png http://www.pharmajournalist.com/eurofins-discovery-announces-discoveryone-integrated-drug-discovery-services/ 2019-04-12T11:42:15+00:00 https://pharmajournalist.com/wp-content/uploads/2017/06/Eurofins.png http://www.pharmajournalist.com/invite-from-ziva-abraham-chair-at-smis-3rd-annual-pharma-microbiology-west-coast-conference-2019/ 2019-04-16T13:55:50+00:00 https://pharmajournalist.com/wp-content/uploads/2019/01/Pharma-Micro-WC_Banner_Pharma-Journalist.jpg http://www.pharmajournalist.com/save-the-date-for-smis-10th-annual-biosimilars-conference-2019/ 2019-04-17T07:25:24+00:00 https://pharmajournalist.com/wp-content/uploads/2019/04/P-298-Biosimilars-300x250.jpg http://www.pharmajournalist.com/china-based-innovation-cdmos-and-parallel-approvals-driving-huge-growth-in-manufacturing-at-cphi-china/ 2019-04-18T11:34:22+00:00 https://pharmajournalist.com/wp-content/uploads/2018/11/CPhIP-MEC-Pharma-Journalist.jpg http://www.pharmajournalist.com/boehringer-ingelheim-acquires-stake-in-soundtalks-nv-begins-pilot-programme/ 2019-04-19T10:02:20+00:00 https://pharmajournalist.com/wp-content/uploads/2017/10/Boehringer-Ingelheim.jpg http://www.pharmajournalist.com/pulmatrix-and-cipla-enter-into-definitive-agreement-for-the-development-and-commercialization-of-pulmazole/ 2019-04-19T10:05:17+00:00 https://pharmajournalist.com/wp-content/uploads/2018/01/Pulmatrix-Logo.jpg http://www.pharmajournalist.com/gilead-and-insitro-announce-strategic-collaboration-to-discover-and-develop-novel-therapies-for-nash/ 2019-04-19T10:06:58+00:00 https://pharmajournalist.com/wp-content/uploads/2017/12/gilead1.jpg